{"id": "CD012281", "boolean": "(Luteinizing Hormone[mesh] OR Progesterone[mesh] OR matrix metalloproteinase 1[mesh] OR matrix metalloproteinase 2[mesh] OR matrix metalloproteinase 3[mesh] OR matrix metalloproteinase 9[mesh] OR \"tissue inhibitor of metalloproteinase-1\"[mesh] OR \"tissue inhibitor of metalloproteinase-2\"[mesh] OR Glycoproteins[mesh] OR Follistatin[mesh] OR intercellular adhesion molecule-1[mesh] OR selectins[mesh] OR t-lymphocytes[mesh] OR natural killer t-cells[mesh] OR hla antigens[mesh] OR hla-a1 antigen[mesh] OR hla-a2 antigen[mesh] OR Integrins[mesh] OR Cysteine-Rich Protein 61[mesh] OR Vascular Endothelial Growth Factor A[mesh:noexp] OR Vitamin D-Binding Protein[mesh:noexp] OR Cytokines[mesh] OR interleukins[mesh] OR interleukin-1[mesh] OR interleukin-6[mesh] OR interleukin-8[mesh] OR interleukin-12[mesh] OR interleukin-13[mesh] OR Epidermal Growth Factor[mesh] OR Fibroblast Growth Factors[mesh] OR Platelet-Derived Growth Factor[mesh:noexp] OR Keratin-19[mesh:noexp] OR Clinical Laboratory Techniques[mesh] OR Endometriosis[mesh:noexp] OR Laboratory Test*[Text Word] OR urinary VDBP corrected for creatinine expression[Text Word] OR MMP*[Text Word] OR proteomic*[Text Word] OR cytokeratin-19[Text Word] OR Total complement level*[Text Word] OR Autoantibodies[Text Word] OR estrogen receptor*[Text Word] OR Anti-thyroid[Text Word] OR Anti-LDL[Text Word] OR MTMMP*[Text Word] OR urinary peptide*[Text Word] OR cyr61[Text Word] OR microRNA*[Text Word] OR cytokine*[Text Word] OR serum marker*[Text Word] OR Integrin*[Text Word] OR Anti-endometrial[Text Word] OR inflammatory marker*[Text Word] OR progesterone receptor*[Text Word] OR serum placental protein*[Text Word] OR sICAM[Text Word] OR Immune cells alteration*[Text Word] OR interleukin*[Text Word] OR Selectin*[Text Word] OR genomic*[Text Word] OR urinary marker*[Text Word] OR Osteopontin*[Text Word] OR Proteolytic enzyme*[Text Word] OR soluble intercellular adhesion[Text Word] OR cell adhesion molecule*[Text Word] OR sVCAM*[Text Word] OR matrix metalloproteinase*[Text Word] OR TIMP*[Text Word] OR Anti-laminin-1[Text Word] OR Follistatin*[Text Word] OR Aromatase P450[Text Word] OR growth factor*[Text Word] OR hepatocyte growth factor[Text Word] OR Endometrial marker*[Text Word] OR CAMs[Text Word] OR Anti-Thomsen Friedenreich antigen*[Text Word] OR microarray*[Text Word] OR VDBP-Cr[Text Word] OR scatter factor*[Text Word] OR Soluble adhesion molecule*[Text Word] OR Anti-transferrin[Text Word] OR Fas ligand*[Text Word] OR cell surface marker*[Text Word] OR leptin*[Text Word] OR Antiphospholipid*[Text Word] OR Cadherin*[Text Word] OR cysteine-rich heparin-binding protein*[Text Word] OR neural marker*[Text Word] OR (EGF[Text Word] OR epidermal growth factor*[Text Word]) OR (MCP-I[Text Word] OR monocyte chemoattractant protein-I[Text Word]) OR (Annexin 1[Text Word] OR Annexin1[Text Word]) OR (FGF[Text Word] OR fibroblast growth factor*[Text Word]) OR (HLA[Text Word] OR human leucocyte antigen*[Text Word]) OR (endometri*[Text Word] AND biops*[Text Word]) OR (EGFR[Text Word] OR epidermal growth factor receptor*[Text Word]) OR (VEGF[Text Word] OR vascular endothelial growth factor*[Text Word]) OR (Ca-19-9[Text Word] OR Ca19-9[Text Word] OR cancer antigen 19-9[Text Word]) OR (ANXA 1[Text Word] OR ANXA1[Text Word]) OR (Luteinizing Hormone*[Text Word] OR LH[Text Word]) OR (Ca-125[Text Word] OR Ca125[Text Word] OR cancer antigen 125[Text Word]) OR (biomarker*[Text Word] OR marker*[Text Word]) OR (PDGF[Text Word] OR platelet derived growth factor*[Text Word]) OR (MIF[Text Word] OR migration inhibitory factor*[Text Word]) OR (VDBP[Text Word] OR vitamin D-binding protein*[Text Word]) OR (sEselectin[Text Word] OR soluble E-selectin[Text Word]) OR (Anti-2HSG[Text Word] OR Heremans-Schmidt glycoprotein[Text Word]) OR (TGF-b[Text Word] OR transforming growth factor beta[Text Word] OR TGFb[Text Word]) OR (TNF-a[Text Word] OR tumour necrosis factor*[Text Word]) OR (IGF-I[Text Word] OR insulin-like growth factor*[Text Word] OR IGF1[Text Word]) OR (T helper*[Text Word] OR T supressor*[Text Word] OR T helper*[Text Word]) OR (TGF-a[Text Word] OR transforming growth factor alfa[Text Word] OR TGFa[Text Word]) OR (PP 14[Text Word] OR PP14[Text Word]) OR (sEcadherin[Text Word] OR soluble E-cadherin[Text Word]) OR (PGP 9*[Text Word] OR PGP9*[Text Word] OR protein gene product*[Text Word])) AND (Endometriosis[mesh] OR Endometrio*[Text Word])", "generated_query": ["\"Retrieve all studies investigating the potential biomarkers, genes, proteins, and cytokines associated with endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, follistatin, selectins, T-lymphocytes, HLA antigens, integrins, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, Keratin-19, clinical laboratory techniques, urinary VDBP corrected for creatinine expression, proteomics, cytokeratin-19, total complement level, autoantibodies, estrogen receptor, anti-thyroid, anti-LDL, urinary peptide, cyr61, microRNA, serum markers, inflammatory markers, progesterone receptor, serum placental protein, sICAM, immune cells alteration, genomic, urinary marker, osteopontin, proteolytic enzymes, soluble intercellular adhesion, cell adhesion molecules, sVCAM, anti-laminin-1, aromatase P450, growth factors, hepatocyte growth factor, endometrial markers, CAMs, anti-Thomsen Friedenreich antigen, microarrays", "What are the biomarkers, markers, and laboratory tests associated with endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Cytokines, interleukins, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, Total complement level, Autoantibodies, estrogen receptor, Anti-thyroid, Anti-LDL, urinary VDBP corrected for creatinine expression, MMPs, proteomics, cytokeratin-19, urinary peptides, cyr61, microRNAs, serum markers, sICAM, Immune cells alteration, Osteopontin, Proteolytic enzymes, soluble intercellular adhesion, cell adhesion molecules, sVCAM, TIMPs, Anti-laminin-1, Aromatase P450,", "What are the biomarkers and molecular pathways associated with endometriosis, and how do they relate to luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, selectins, T-lymphocytes, HLA antigens, integrins, vascular endothelial growth factor, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, and urinary VDBP corrected for creatinine expression?", "What is the relationship between endometriosis and various biomarkers, including luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, cytokines, growth factors, and integrins, among others, and how do these biomarkers potentially contribute to the pathogenesis of endometriosis?", "What biomarkers, cytokines, growth factors, and cellular markers are associated with endometriosis, and what is their relationship to the disease progression?", "What are the potential biomarkers, hormones, cytokines, growth factors, and cell adhesion molecules associated with endometriosis? Specifically, I am looking for studies that investigate the levels of Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, cytokines, interleukins, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, Total complement level, Autoantibodies, estrogen receptor, Anti-thyroid antibodies, Anti-LDL antibodies, MTMMP, urinary peptides, cyr61, microRNAs, serum markers, Anti-endometrial antibodies, inflammatory markers, progesterone receptor, serum placental proteins, sICAM, immune cells alterations, genomic markers, urinary markers, Osteopontin, Proteolytic enzymes, soluble intercellular adhesion,", "What biomarkers, growth factors, cytokines, adhesion molecules, and immune cells alterations are associated with endometriosis?", "What biomarkers, growth factors, cytokines, glycoproteins, and cell surface markers have been associated with endometriosis? Specifically, I am interested in studies that investigate Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, Integrins, Vascular Endothelial Growth Factor A, Vitamin D-binding Protein, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, cytokeratin-19, Autoantibodies, estrogen receptor, Anti-thyroid, Anti-LDL, microRNA, sICAM, Immune cells alterations, genomic markers, urinary markers, Osteopontin, Proteolytic enzymes, soluble intercellular adhesion, cell adhesion molecules, sVCAM, TIMPs, Anti-laminin-1, Aromatase P450, hepatocyte growth factor, Endometrial markers, CAMs, Anti-Thomsen Friedenreich antigen, microarrays, VDBP-Cr, scatter", "What biomarkers, cytokines, growth factors, glycoproteins, immune cells alterations, integrins, interleukins, matrix metalloproteinases, proteolytic enzymes, and soluble adhesion molecules are associated with endometriosis?", "What are the markers and biomolecules associated with endometriosis, including luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, follistatin, intercellular adhesion molecules, selectins, T-lymphocytes, HLA antigens, integrins, cytokines, growth factors, clinical laboratory techniques, urinary markers, proteomic analyses, and genomic analyses?"]}
{"id": "CD011053", "boolean": "(Venous Thromboembolism[mesh:noexp] OR Thrombosis[mesh:noexp] OR Venous Thrombosis[mesh:noexp] OR Upper Extremity Deep Vein Thrombosis[mesh:noexp] OR Pulmonary Embolism[mesh:noexp] OR Thromboembolism[mesh:noexp] OR PE[Title/Abstract] OR (thromboemboli*[Title/Abstract] OR microthrombus[Title/Abstract] OR thrombus[Title/Abstract] OR thrombo*[Title/Abstract] OR thrombilic[Title/Abstract] OR thrombotic[Title/Abstract]) OR (DVT[Title/Abstract] OR VTE[Title/Abstract]) OR (pulmonary[Title/Abstract] AND embol*[Title/Abstract]) OR (lung[Title/Abstract] AND thrombo*[Title/Abstract]) OR (pulmonary[Title/Abstract] AND thrombo*[Title/Abstract]) OR (lung[Title/Abstract] AND embol*[Title/Abstract])) AND (Lung[mesh] OR magnetic resonance imaging[mesh:noexp] OR tomography, x-ray[mesh] OR tomography scanners, x-ray computed[mesh:noexp] OR perfusion imaging[mesh:noexp] OR diagnostic imaging[mesh:noexp] OR Pulmonary Artery[mesh:noexp] OR Diffusion Magnetic Resonance Imaging[mesh:noexp] OR Phlebography[mesh:noexp] OR tomography[mesh:noexp] OR ultrasonography[mesh:noexp] OR Ventilation-Perfusion Ratio[mesh:noexp] OR tomography, emission-computed[mesh] OR ultrasonography, prenatal[mesh] OR ultrasonics[mesh:noexp] OR radionuclide imaging[mesh:noexp] OR Angiography[mesh:noexp] OR magnetic resonance angiography[mesh:noexp] OR ultrasonography, doppler[mesh] OR ultrasonic*[Title/Abstract] OR SPECT[Title/Abstract] OR scintigraph*[Title/Abstract] OR MRA[Title/Abstract] OR tomodensitometry[Title/Abstract] OR sonogram*[Title/Abstract] OR sonograph*[Title/Abstract] OR 3d-cta[Title/Abstract] OR echograph*[Title/Abstract] OR multislice[Title/Abstract] OR multi-slice[Title/Abstract] OR ultrasonogra*[Title/Abstract] OR perfusion[Title/Abstract] OR three dimensional-ct[Title/Abstract] OR ultrasound[Title/Abstract] OR (doppler[Title/Abstract] OR duplex[Title/Abstract]) OR ((CT[Title/Abstract] OR CAT[Title/Abstract]) AND (angiogra*[Title/Abstract] OR arteriogra*[Title/Abstract] OR tomograph*[Title/Abstract])) OR (pulmonary[Title/Abstract] AND angiogr*[Title/Abstract]) OR (comput*[Title/Abstract] AND tomogra*[Title/Abstract]) OR (cat[Title/Abstract] AND scan*[Title/Abstract]) OR (ct[Title/Abstract] AND scan*[Title/Abstract]) OR (contrast[Title/Abstract] AND US[Title/Abstract]) OR (VQ[Title/Abstract] OR V*[Title/Abstract] OR V*[Title/Abstract]) OR (CTA[Title/Abstract] OR CTPA[Title/Abstract]) OR (MDCT[Title/Abstract] OR MSCT[Title/Abstract]) OR (single-slice[Title/Abstract] OR singleslice[Title/Abstract]) OR (USS[Title/Abstract] OR DUS[Title/Abstract] OR CDUS[Title/Abstract] OR CEUS[Title/Abstract]) OR (lung[Title/Abstract] AND angiogr*[Title/Abstract]) OR (multi-row[Title/Abstract] OR multirow[Title/Abstract]) OR ((magnetic resonance[Title/Abstract] OR MR[Title/Abstract] OR MRI[Title/Abstract] OR NMR[Title/Abstract]) AND (angiogra*[Title/Abstract] OR arteriogra*[Title/Abstract]))) AND (Pregnancy Trimesters[mesh] OR Pregnancy[mesh] OR prepartum[Title/Abstract] OR antepartum[Title/Abstract] OR prenatal[Title/Abstract] OR antenatal[Title/Abstract] OR trimester*[Title/Abstract] OR pregnan*[Title/Abstract])", "generated_query": ["What are the imaging techniques used to diagnose venous thromboembolism, thrombosis, upper extremity deep vein thrombosis, and pulmonary embolism in pregnant women during any trimester?", "What imaging techniques are effective for diagnosing venous thromboembolism, including pulmonary embolism, in pregnant women during any trimester of pregnancy?", "\"Retrieve articles on the association between venous thromboembolism, thrombosis, pulmonary embolism, or deep vein thrombosis, and imaging techniques including magnetic resonance imaging, x-ray tomography, ultrasonography, and angiography during pregnancy. The query should also include keywords such as thrombo*, microthrombus, DVT, VTE, pulmonary, lung, and perfusion imaging.\"", "What is the relationship between imaging modalities and venous thromboembolism in pregnant women?", "What are the most effective imaging modalities for diagnosing venous thromboembolism in pregnant women during different trimesters of pregnancy?", "What diagnostic imaging techniques are effective in detecting venous thromboembolism, thrombosis, pulmonary embolism, and related conditions in pregnant women, including those in different trimesters? The search should include terms such as DVT, VTE, lung angiography, magnetic resonance imaging, ultrasonography, and tomography, among others, and exclude articles that focus on non-pregnant populations or those with unrelated conditions.", "What diagnostic imaging techniques are effective in detecting venous thromboembolism or pulmonary embolism during pregnancy, including the use of magnetic resonance imaging, ultrasound, computed tomography, and angiography?", "What is the association between venous thromboembolism and pregnancy, as studied through various imaging modalities including ultrasonography, magnetic resonance imaging, and angiography?", "\"What is the association between venous thromboembolism, pulmonary embolism, and deep vein thrombosis with lung and pulmonary artery imaging during pregnancy and the antepartum period?\"", "What are the diagnostic imaging techniques and modalities for identifying venous thromboembolism and pulmonary embolism in pregnant women during all trimesters of pregnancy, including prepartum and antepartum periods?"]}
{"id": "CD011602", "boolean": "(Ultrasonography[mesh] OR ultrason*[All Fields] OR ultrasound*[All Fields] OR echograph*[All Fields] OR echotomograph*[All Fields] OR doppler*[All Fields] OR B-mode[All Fields] OR B-scan[All Fields] OR grey*[All Fields]) AND (Liver Cirrhosis[mesh] OR (hepatic[All Fields] OR liver[All Fields]) AND (fibrosis[All Fields] OR cirrhosis[All Fields]))", "generated_query": ["What is the diagnostic accuracy of ultrasonography, echography, doppler imaging, and B-mode and B-scan ultrasound in detecting liver cirrhosis or fibrosis in patients with hepatic or liver disorders?", "What is the efficacy of ultrasonography, echography, and doppler imaging techniques in diagnosing liver fibrosis or cirrhosis in patients with liver disease?", "What is the diagnostic accuracy of ultrasonography, echography, Doppler, and B-mode/B-scan for detecting liver fibrosis or cirrhosis in patients with hepatic or liver disease?", "What is the effectiveness of ultrasonography, echography, doppler imaging, and B-mode or B-scan techniques in detecting liver fibrosis or cirrhosis, or hepatic fibrosis or cirrhosis, among patients with liver disease?", "What is the diagnostic accuracy of various ultrasonography techniques, such as B-mode, Doppler, and echotomography, in detecting liver cirrhosis or fibrosis in patients with hepatic or liver diseases?", "What is the effectiveness of ultrasound techniques, including ultrasonography, echography, and Doppler, in diagnosing and monitoring liver fibrosis or cirrhosis in patients with hepatic or liver conditions?", "What is the efficacy of ultrasonography, echography, Doppler, and B-mode in detecting liver cirrhosis or fibrosis in patients with hepatic or liver conditions?", "What is the effectiveness of ultrasonography, echography, doppler, and B-mode scans in diagnosing and monitoring liver fibrosis and cirrhosis in patients with hepatic or liver conditions?", "\"Retrieve studies on the use of ultrasonography, echography, doppler imaging, and B-mode or B-scan for the diagnosis of liver cirrhosis or fibrosis in the hepatic or liver tissues.\"", "What is the effectiveness of ultrasonography, echography, doppler, and B-mode scans in the diagnosis and monitoring of liver cirrhosis or fibrosis in patients with hepatic or liver conditions?"]}
{"id": "CD010657", "boolean": "(Succimer[mesh] OR Organotechnetium Compounds[mesh:noexp] OR (Organometallic Compounds[mesh:noexp] AND Technetium[mesh:noexp]) OR Radionuclide Imaging[mesh:noexp] OR Ultrasonography[mesh:noexp] OR Ultrasonography, Doppler[mesh] OR Ultrasonography, Interventional[mesh:noexp] OR DMSA[Text Word] OR dimercaptosuccin*[Text Word] OR dimercapto-succin*[Text Word] OR scintigra*[Text Word] OR (ultrasound[Text Word] OR ultrasonogra*[Text Word] OR echogr*[Text Word] OR sonogr*[Text Word])) AND (Infant[mesh] OR Child[mesh] OR Adolescent[mesh:noexp] OR Puberty[mesh] OR Pediatrics[mesh:noexp] OR Schools[mesh] OR infant*[Text Word] OR infancy[Text Word] OR newborn*[Text Word] OR baby[Text Word] OR babies[Text Word] OR neonat*[Text Word] OR preterm[Text Word] OR prematur*[Text Word] OR postmatur*[Text Word] OR child*[Text Word] OR schoolchild*[Text Word] OR school age*[Text Word] OR preschool*[Text Word] OR kid[Text Word] OR kids[Text Word] OR toddler*[Text Word] OR adolesc*[Text Word] OR teen*[Text Word] OR boy*[Text Word] OR girl*[Text Word] OR minor[Text Word] OR minors[Text Word] OR pubert*[Text Word] OR pubescen*[Text Word] OR prepubescen*[Text Word] OR paediatric*[Text Word] OR pediatric*[Text Word] OR nursery school*[Text Word] OR kindergar*[Text Word] OR primary school*[Text Word] OR secondary school*[Text Word] OR elementary school*[Text Word] OR high school*[Text Word] OR highschool*[Text Word]) AND (Vesico-Ureteral Reflux[mesh:noexp] OR vesicoureteral reflux[Text Word] OR vesico-ureteral reflux[Text Word] OR VUR[Text Word])", "generated_query": ["What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds with technetium, radionuclide imaging, ultrasonography (including Doppler and interventional), DMSA, and scintigraphy, as well as ultrasound, echography, sonography in diagnosing and managing vesico-ureteral reflux in infants, children, adolescents, and those in school settings?", "What is the effectiveness of Succimer, Organotechnetium Compounds, Organometallic Compounds, Technetium, Radionuclide Imaging, Ultrasonography, Doppler Ultrasonography, Interventional Ultrasonography, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, ultrasound, ultrasonogra*, echogr*, sonogr* in Infant, Child, Adolescent, Puberty, Pediatrics, Schools, vesicoureteral reflux, Vesico-Ureteral Reflux, newborn, baby, neonat*, preterm, prematur*, postmatur*, schoolchild*, school age*, preschool*, kid, kids, toddler*, adolesc*, teen*, boy*, girl*, minor*, minors*, pubert*, pubescen*, prepubescen*, paediatric*, pediatric*, nursery school*, kindergar*, primary school*, secondary school*, elementary school*, high school* and highschool*?", "What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds combined with technetium, radionuclide imaging, ultrasonography, Doppler ultrasonography, interventional ultrasonography, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, and various ultrasound techniques for the diagnosis and treatment of Vesico-Ureteral Reflux in infants, children, adolescents, and those in puberty, including those in schools?", "What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds with technetium, radionuclide imaging, ultrasound, doppler ultrasound, interventional ultrasound, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, and vesico-ureteral reflux in the diagnosis and management of VUR in infants, children, adolescents, and in school settings?", "What is the effectiveness of Succimer, Organotechnetium Compounds, Organometallic Compounds, Technetium, Radionuclide Imaging, Ultrasonography, Ultrasonography, Doppler, Ultrasonography, Interventional, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, ultrasound, ultrasonogra*, echogr*, sonogr*, Infant, Child, Adolescent, Puberty, Pediatrics, Schools, infant*, infancy, newborn*, baby, babies, neonat*, preterm, prematur*, postmatur*, child*, schoolchild*, school age*, preschool*, kid, kids, toddler*, adolesc*, teen*, boy*, girl*, minor, minors, pubert*, pubescen*, prepubescen*, paediatric*, pediatric*, nursery school*, kindergar*, primary school*, secondary school*, elementary school*, high school*, highschool*, and Vesico-Ureteral Reflux in retrieving relevant documents related to VUR in infants, children, adolescents, and pubertal individuals?", "What is the effectiveness of Succimer, Organotechnetium Compounds, Organometallic Compounds combined with Technetium, Radionuclide Imaging, Ultrasonography, Ultrasonography Doppler, Ultrasonography Interventional, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, ultrasound, ultrasonogra*, echogr*, sonogr* in infants, children, adolescents, puberty, pediatrics, schools, vesico-ureteral reflux, VUR, vesicoureteral reflux, in retrieving relevant documents in a semantic-based search engine?", "What is the effectiveness of Succimer, Organotechnetium Compounds, Organometallic Compounds, Technetium, Radionuclide Imaging, Ultrasonography, Doppler Ultrasonography, Interventional Ultrasonography, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, ultrasound, echogr*, sonogr*, Infant, Child, Adolescent, Puberty, Pediatrics, Schools, infant*, infancy, newborn*, baby, babies, neonat*, preterm, prematur*, postmatur*, child*, schoolchild*, school age*, preschool*, kid, kids, toddler*, adolesc*, teen*, boy*, girl*, minor, minors, pubert*, pubescen*, prepubescen*, paediatric*, pediatric*, nursery school*, kindergar*, primary school*, secondary school*, elementary school*, high school*, and highschool* in the diagnosis of Vesico-Ureteral Reflux?", "What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds with technetium, radionuclide imaging, ultrasonography (including Doppler and interventional), DMSA, dimercaptosuccin*, scintigra*, and ultrasound in detecting and managing vesico-ureteral reflux in infants, children, adolescents, and those in school, including those who are preterm or postmature?", "What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds with technetium, radionuclide imaging, ultrasonography, Doppler ultrasonography, interventional ultrasonography, DMSA, dimercaptosuccin*, dimercapto-succin*, scintigra*, and various ultrasound techniques in detecting vesico-ureteral reflux in infants, children, adolescents, and school-aged individuals?", "What is the effectiveness of succimer, organotechnetium compounds, organometallic compounds with technetium, radionuclide imaging, ultrasonography (including Doppler and interventional), DMSA, and scintigraphy (as well as related terms) in detecting vesico-ureteral reflux in infants, children, adolescents, and those in school (including related terms) with VUR?"]}
{"id": "CD009263", "boolean": "((((neuroblastoma) OR (neuroblastomas) OR (neuroblast*)) OR ((ganglioneuroblastoma) OR (ganglioneuroblastomas) OR (gan glioneuroblast*)) OR ((neuroepithelioma) OR (neuroepitheliomas) OR (neuroepitheliom*)) OR ((esthesioneuroblastoma) OR (esthesioneuroblastomas) OR (esthesioneuroblastom*))) OR (peripheral primitive neuroectodermal tumors OR peripheral primitive neuroectodermal tumours OR peripheral primitive neuroectodermal neoplasm OR primitive neuroectodermal tumor, extracranial OR neuroectodermal tumor, peripheral OR neuroectodermal tumors, peripheral OR peripheral neuroectodermal tumor OR peripheral neuroectodermal tumors OR tumor, peripheral neuroectodermal OR tumors, peripheral neuroectodermal OR (ppnet OR pnet OR PNET*) OR peripheral primitive neuroectodermal tumor OR peripheral primitive neuroectodermal tumour OR extracranial primitive neuroectodermal tumor OR extracranial primitive neuroectodermal tumour OR extracranial primitive neuroectodermal tumors OR extracranial primitive neuroectodermal tumour OR neuroectodermal neoplasm, peripheral primitive OR neuro ectodermal tumor, peripheral primitive) OR (esthesioneuroblastomas, olfactory OR olfactory esthesioneuroblastoma OR olfactory esthesioneuroblastoma OR esthesioneuroblastoma, paranasal sinus-nasal cavity OR esthesioneuroblastoma, paranasal sinus nasal cavity OR neuroblastoma, olfactory OR neuroblastomas, olfactory OR olfactory neuroblastomas OR paranasal sinus-nasal cavity esthesioneuroblastoma OR paranasal sinus nasal cavity esthesioneuroblastoma OR esthesioneuroblastoma OR esthesioneuroblastomas OR olfactory neuroblastoma) AND ((mibg OR iodine-123 metaiodobenzylguanidine imaging OR iodine-123 metaiodobenzylguanidine Imag* OR metaiodobenzyl guanidine OR Metaiodobenzylguanidin* OR metaiodobenzylguanidine scintigraphy OR metaiodobenzylguanidine scintigraph*) OR (123I-mIBG) OR (3 iodobenzylguanidine OR meta-iodobenzylguanidine OR meta iodobenzylguanidine OR iobenguane OR m iodobenzylguanidine OR m iodobenzylguanidine OR (iobenguane AND (131I) OR (3-IodoND (131I) AND benzyl) AND guanidine) OR 3-iodobenzylguanidine, 123i labeled OR 123i labeled 3-iodobenzylguanidine OR 3 iodobenzylguanidine, 123i labeled OR meta-iodobenzylguanidine OR meta iodobenzylguanidine OR m-iodobenzylguanidine OR m iodobenzylguanidine OR iobenguane (131I) OR (3-Iodo131I) benzyl) guanidine) OR (77679-27-7[rn]) OR (positron emission tomography OR positron emission Tomograph* OR tomography, positron-emission OR tomography, positron emission OR pet scan OR pet scans OR scan, pet OR scans, pet OR PET Scan* OR PET) OR (spect OR spect-ct OR 18F-FDG-PET-CT OR single photon emission computed tomography OR single photon emission computerized tomography OR single photon emission computerised tomography OR tomography, emission-computed, single photon) OR (single photon emission computed radionuclide tomography OR single photon emission ct scan OR single photon emission ct scan OR single photon emission computer assisted tomography OR 18 f-fdg-pet OR 18-fluorodeoxy* OR 18fluorodeoxy* OR fdg pet OR fdg pet OR 18f fdg* OR single photon emission computed radionuclide Tomograph* OR single photon emission ct Scan* OR single photon emission ct scan* OR single photon emission computer assisted Tomograph* OR single photon emission computed Tomograph* OR single photon emission computerized tomograph* OR single photon emission computerised tomograph* OR fluorodeoxyglucose f18))) NOT case reports[pt] AND 1940/01/01:2012/09/21[crdt] ", "generated_query": ["What is the effectiveness of different imaging modalities, including 123I-MIBG, PET, and SPECT, in diagnosing and evaluating peripheral primitive neuroectodermal tumors (PNETs) such as neuroblastoma, ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma, and how do they compare to each other?", "What is the effectiveness of using MIBG or PET imaging in the diagnosis of peripheral primitive neuroectodermal tumors and related conditions such as neuroblastoma, ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma, while excluding case reports, from 1940 to 2012?", "What is the efficacy of imaging techniques such as MIBG, PET, and SPECT in diagnosing and monitoring neuroblastoma, ganglioneuroblastoma, neuroepithelioma, esthesioneuroblastoma, and peripheral primitive neuroectodermal tumors in non-case report studies published between January 1, 1940, and September 21, 2012?", "What is the effectiveness of mibg imaging and other neuroimaging techniques in detecting and staging neuroblastoma, ganglioneuroblastoma, neuroepithelioma, esthesioneuroblastoma, and peripheral primitive neuroectodermal tumors, excluding case reports, from 1940 to 2012?", "What is the effectiveness of various imaging modalities, including positron emission tomography, single photon emission computed tomography, and iodine-123 metaiodobenzylguanidine imaging, in the diagnosis and management of neuroblastoma, ganglioneuroblastoma, neuroepithelioma, esthesioneuroblastoma, and peripheral primitive neuroectodermal tumors? The search should exclude case reports and be limited to articles published between 1940 and 2012.", "\"Retrieve systematic reviews on the diagnosis and treatment of neuroblastoma and related tumors such as ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma, as well as peripheral primitive neuroectodermal tumors, utilizing imaging techniques such as MIBG scintigraphy, PET scan, and SPECT-CT. Exclude case reports. The search should cover articles published between 1940 and September 2012.\"", "What is the effectiveness of various imaging techniques for detecting and diagnosing neuroblastoma, ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma, as well as peripheral primitive neuroectodermal tumors (PPNET/PNET), including but not limited to 123I-metaiodobenzylguanidine (MIBG) imaging, positron emission tomography (PET), and single photon emission computed tomography (SPECT)? Please exclude case reports and limit the search to articles published between 1940 and 2012.", "What is the effectiveness of diagnostic imaging techniques such as MIBG scintigraphy, PET scans, and SPECT-CT in detecting peripheral primitive neuroectodermal tumors, including neuroblastoma, ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma, and how do they compare in terms of accuracy and reliability, based on systematic reviews published from 1940 to September 21, 2012, excluding case reports?", "What is the effectiveness of MIBG imaging and PET/CT scans for the diagnosis and treatment of peripheral primitive neuroectodermal tumors (PPNETs) including neuroblastoma, ganglioneuroblastoma, neuroepithelioma, and esthesioneuroblastoma in patients from 1940 to 2012, excluding case reports?", "What is the efficacy of mibg imaging, PET scans, and SPECT-CT in detecting and diagnosing neuroblastomas, ganglioneuroblastomas, neuroepitheliomas, and esthesioneuroblastomas, as well as peripheral primitive neuroectodermal tumors, including PNET, ppnet, and extracranial primitive neuroectodermal tumors, in non-case report studies published between 1940 and September 21, 2012?"]}
{"id": "CD011912", "boolean": "(Infant, Newborn[mesh] OR neonate*[All Fields] OR infant*[All Fields] OR newborn[All Fields]) AND (oximetry[mesh] OR oximetry[All Fields] OR pulse oximetr*[All Fields] OR oxygen saturation[All Fields] OR O2 saturation[All Fields]) AND (Heart Defects, Congenital[mesh] OR Heart Valve Diseases[mesh] OR tetralogy fallot*[All Fields] OR cyanotic heart[All Fields] OR congenital heart[All Fields] OR congenital cardiac[All Fields] OR aortic coarctation[All Fields] OR valve diseases[All Fields] OR hypoplastic syndrome[All Fields] OR pulmonary atresia[All Fields] OR interruption of the aortic arch[All Fields] OR valve stenosis[All Fields] OR pulmonary atresia[All Fields])", "generated_query": ["What is the effectiveness of oximetry or pulse oximetry on newborns with congenital heart defects, such as tetralogy of Fallot, aortic coarctation, valve stenosis, or pulmonary atresia?", "What is the effectiveness of oximetry in detecting and monitoring heart defects and valve diseases in neonates, infants, and newborns with conditions such as tetralogy of Fallot, cyanotic heart, aortic coarctation, hypoplastic syndrome, pulmonary atresia, interruption of the aortic arch, valve stenosis, and pulmonary atresia?", "What is the effectiveness of pulse oximetry in detecting congenital heart defects in newborns and infants with conditions such as tetralogy of Fallot, cyanotic heart, aortic coarctation, hypoplastic syndrome, pulmonary atresia, interruption of the aortic arch, and valve stenosis?", "What is the relationship between pulse oximetry, oxygen saturation, and congenital heart defects in newborns and infants, including but not limited to conditions such as tetralogy of Fallot, cyanotic heart disease, aortic coarctation, and pulmonary atresia?", "What is the effectiveness of oximetry in detecting heart defects in newborns and infants with congenital cardiac abnormalities such as tetralogy of Fallot, cyanotic heart, aortic coarctation, valve stenosis, pulmonary atresia, and interruption of the aortic arch?", "What is the effectiveness of oximetry in diagnosing and monitoring congenital heart defects in neonates and infants with conditions such as tetralogy of Fallot, cyanotic heart, hypoplastic syndrome, aortic coarctation, pulmonary atresia, and interruption of the aortic arch?", "What is the association between pulse oximetry, oxygen saturation, and heart defects in newborns, including congenital heart disease, aortic coarctation, hypoplastic syndrome, pulmonary atresia, and valve stenosis?", "What is the effectiveness of oximetry in detecting and monitoring oxygen saturation levels in infants with congenital heart defects, including those with tetralogy of Fallot, cyanotic heart disease, aortic coarctation, pulmonary atresia, interruption of the aortic arch, valve stenosis, and hypoplastic syndrome?", "What is the efficacy of oximetry in detecting and managing congenital heart defects in neonates and infants with conditions such as tetralogy of Fallot, cyanotic heart, aortic coarctation, pulmonary atresia, interruption of the aortic arch, valve stenosis, and hypoplastic syndrome?", "What is the effectiveness of oximetry in detecting and monitoring oxygen saturation in infants with congenital heart defects, including conditions such as tetralogy of Fallot, aortic coarctation, pulmonary atresia, and interruption of the aortic arch?"]}
{"id": "CD012010", "boolean": "(Pancreatitis, Acute Necrotizing[mesh:noexp] OR Pancreatitis[mesh:noexp] OR Pancreas[mesh:noexp] OR (acute[All Fields] AND pancrea*[All Fields]) OR (necro*[All Fields] AND pancrea*[All Fields]) OR (inflam*[All Fields] AND pancrea*[All Fields]) OR (pancrea*[All Fields] AND (interstitial[All Fields] OR edema*[All Fields] OR oedema*[All Fields]))) AND (Amylases[mesh] OR Lipase[mesh] OR Trypsinogen[mesh] OR C-Reactive Protein[mesh] OR L-Lactate Dehydrogenase[mesh] OR procalcitonin[All Fields] OR (\"c-reactive protein\"[All Fields] OR \"c reactive protein\"[All Fields] OR CRP[All Fields]) OR (amylase[All Fields] OR lipase[All Fields] OR trypsinogen[All Fields] OR hyperamylasaemia[All Fields] OR hyperamylasemia[All Fields]) OR (\"lactate dehydrogenase\"[All Fields] OR LDH[All Fields]))", "generated_query": ["What is the effectiveness of biomarkers such as amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin in the diagnosis of acute pancreatitis, including acute necrotizing pancreatitis, interstitial edema, and oedema?", "What is the association between acute necrotizing pancreatitis or other types of pancreatitis with biomarkers such as amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin?", "What is the effectiveness of amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin in diagnosing acute necrotizing pancreatitis or pancreatitis, and how do they relate to interstitial edema, oedema, or inflammation in the pancreas?", "What is the relationship between acute pancreatitis and levels of amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin?", "What is the effectiveness of using Amylases, Lipase, Trypsinogen, C-Reactive Protein, L-Lactate Dehydrogenase, and procalcitonin to diagnose acute pancreatitis or acute necrotizing pancreatitis?", "What is the effectiveness of diagnostic tests such as amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin in identifying acute pancreatitis and acute necrotizing pancreatitis, as well as their association with pancreas inflammation, edema, and interstitial changes?", "What is the relationship between acute necrotizing pancreatitis or pancreatitis, pancreas, acute or necrosis or inflammation of the pancreas, and amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin in the context of a systematic review?", "What is the relationship between acute necrotizing pancreatitis, pancreatitis, pancreas, inflammation, and biomarkers including amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin, as well as hyperamylasemia and LDH?", "\"What is the association between acute pancreatitis and the biomarkers amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin? Are there any studies that investigate the relationship between acute necrotizing pancreatitis and these biomarkers? Do studies examine the diagnostic accuracy of these biomarkers for acute pancreatitis or its complications such as interstitial edema or inflammation?\"", "What is the association between acute necrotizing pancreatitis, pancreatitis, pancreas, inflammation, and levels of amylases, lipase, trypsinogen, C-reactive protein, L-lactate dehydrogenase, and procalcitonin in patients with pancreatitis?"]}
{"id": "CD012165", "boolean": "(Luteinizing Hormone[mesh] OR Progesterone[mesh] OR matrix metalloproteinase 1[mesh] OR matrix metalloproteinase 2[mesh] OR matrix metalloproteinase 3[mesh] OR matrix metalloproteinase 9[mesh] OR \"tissue inhibitor of metalloproteinase-1\"[mesh] OR \"tissue inhibitor of metalloproteinase-2\"[mesh] OR Glycoproteins[mesh] OR Follistatin[mesh] OR intercellular adhesion molecule-1[mesh] OR selectins[mesh] OR t-lymphocytes[mesh] OR natural killer t-cells[mesh] OR Antibodies, Antiphospholipid[mesh] OR hla antigens[mesh] OR hla-a1 antigen[mesh] OR hla-a2 antigen[mesh] OR Integrins[mesh] OR Cysteine-Rich Protein 61[mesh] OR Vascular Endothelial Growth Factor A[mesh:noexp] OR Vitamin D-Binding Protein[mesh:noexp] OR Cytokines[mesh] OR interleukins[mesh] OR interleukin-1[mesh] OR interleukin-6[mesh] OR interleukin-8[mesh] OR interleukin-12[mesh] OR interleukin-13[mesh] OR Epidermal Growth Factor[mesh] OR Fibroblast Growth Factors[mesh] OR Platelet-Derived Growth Factor[mesh:noexp] OR Keratin-19[mesh:noexp] OR Clinical Laboratory Techniques[mesh] OR Endometriosis[mesh:noexp] OR sICAM[Text Word] OR Anti-Thomsen Friedenreich antigen*[Text Word] OR Endometrial marker*[Text Word] OR cell adhesion molecule*[Text Word] OR cysteine-rich heparin-binding protein*[Text Word] OR hepatocyte growth factor[Text Word] OR serum placental protein*[Text Word] OR urinary VDBP corrected for creatinine expression[Text Word] OR Anti-endometrial[Text Word] OR cytokeratin-19[Text Word] OR Anti-thyroid[Text Word] OR Selectin*[Text Word] OR progesterone receptor*[Text Word] OR MTMMP*[Text Word] OR TIMP*[Text Word] OR Immune cells alteration*[Text Word] OR soluble intercellular adhesion[Text Word] OR MMP*[Text Word] OR Osteopontin*[Text Word] OR VDBP-Cr[Text Word] OR urinary marker*[Text Word] OR sVCAM*[Text Word] OR Antiphospholipid*[Text Word] OR Soluble adhesion molecule*[Text Word] OR microRNA*[Text Word] OR Fas ligand*[Text Word] OR estrogen receptor*[Text Word] OR Anti-LDL[Text Word] OR microarray*[Text Word] OR neural marker*[Text Word] OR cyr61[Text Word] OR genomic*[Text Word] OR urinary peptide*[Text Word] OR scatter factor*[Text Word] OR cell surface marker*[Text Word] OR interleukin*[Text Word] OR leptin*[Text Word] OR Integrin*[Text Word] OR proteomic*[Text Word] OR Laboratory Test*[Text Word] OR CAMs[Text Word] OR cytokine*[Text Word] OR matrix metalloproteinase*[Text Word] OR serum marker*[Text Word] OR Total complement level*[Text Word] OR Follistatin*[Text Word] OR growth factor*[Text Word] OR Proteolytic enzyme*[Text Word] OR Anti-transferrin[Text Word] OR Anti-laminin-1[Text Word] OR Autoantibodies[Text Word] OR Cadherin*[Text Word] OR Aromatase P450[Text Word] OR inflammatory marker*[Text Word] OR (endometri*[Text Word] AND biops*[Text Word]) OR (sEcadherin[Text Word] OR soluble E-cadherin[Text Word]) OR (TNF-a[Text Word] OR tumour necrosis factor*[Text Word]) OR (FGF[Text Word] OR \"fibroblast growth factor*\"[Text Word]) OR (PDGF[Text Word] OR \"platelet derived growth factor*\"[Text Word]) OR (biomarker*[Text Word] OR marker*[Text Word]) OR (EGFR[Text Word] OR \"epidermal growth factor receptor*\"[Text Word]) OR (TGF-b[Text Word] OR \"transforming growth factor beta\"[Text Word] OR TGFb[Text Word]) OR (PP 14[Text Word] OR PP14[Text Word]) OR (VEGF[Text Word] OR \"vascular endothelial growth factor*\"[Text Word]) OR (VDBP[Text Word] OR vitamin D-binding protein*[Text Word]) OR (MIF[Text Word] OR migration inhibitory factor*[Text Word]) OR (IGF-I[Text Word] OR \"insulin-like growth factor*\"[Text Word] OR IGF1[Text Word]) OR (T helper*[Text Word] OR T supressor*[Text Word] OR T helper*[Text Word]) OR (MCP-I[Text Word] OR monocyte chemoattractant protein-I[Text Word]) OR (Anti-2HSG[Text Word] OR Heremans-Schmidt glycoprotein[Text Word]) OR (ANXA 1[Text Word] OR ANXA1[Text Word]) OR (Annexin 1[Text Word] OR Annexin1[Text Word]) OR (EGF[Text Word] OR \"epidermal growth factor*\"[Text Word]) OR (Luteinizing Hormone*[Text Word] OR LH[Text Word]) OR (sEselectin[Text Word] OR soluble E-selectin[Text Word]) OR (PGP 9*[Text Word] OR PGP9*[Text Word] OR protein gene product*[Text Word]) OR (TGF-a[Text Word] OR \"transforming growth factor alfa\"[Text Word] OR TGFa[Text Word]) OR (Ca-125[Text Word] OR Ca125[Text Word] OR cancer antigen 125[Text Word]) OR (HLA[Text Word] OR human leucocyte antigen*[Text Word]) OR (Ca-19-9[Text Word] OR Ca19-9[Text Word] OR cancer antigen 19-9[Text Word])) AND (Endometriosis[mesh] OR Endometrio*[Text Word])", "generated_query": ["What is the role of Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, selectins, T-lymphocytes, natural killer T-cells, antibodies, HLA antigens, integrins, cytokines, growth factors, and various markers and molecules such as sICAM, cysteine-rich heparin-binding protein, hepatocyte growth factor, VDBP-Cr, microRNA, Fas ligand, estrogen receptor, and various others, in the pathogenesis of endometriosis?", "What are the effects of luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, follistatin, intercellular adhesion molecules, selectins, T-lymphocytes, natural killer T-cells, antibodies against antiphospholipids, HLA antigens, integrins, cysteine-rich protein 61, vascular endothelial growth factor A, vitamin D-binding protein, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, sICAM, anti-Thomsen Friedenreich antigen, endometrial markers, cell adhesion molecules, cysteine-rich heparin-binding protein, hepatocyte growth factor, serum placental proteins, urinary VDBP corrected for creatinine expression, anti-endometrial antibodies, cytokeratin-19, anti-thyroid antibodies, selectins, progesterone receptor, MTMMP, TIMP, immune cell alterations, soluble intercellular adhesion, MMP, osteopontin, VDBP-Cr, urinary markers, sVCAM, antiphospholipid antibodies,", "What are the biomarkers, cytokines, growth factors, and immune cell alterations associated with endometriosis? Specifically, which ones are related to Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, antibodies, antiphospholipid, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, sICAM, Anti-Thomsen Friedenreich antigen, Endometrial marker, cell adhesion molecule, cysteine-rich heparin-binding protein, hepatocyte growth factor, serum placental protein, urinary VDBP corrected for creatinine expression, Anti-endometrial, cytokeratin-19, Anti-thyroid, Selectin, progesterone receptor, MTMMP, TIMP, Immune cells alteration, soluble intercellular adhesion, MMP, O", "What are the markers of endometriosis and how do they relate to immune cell alterations, cytokines, growth factors, and proteolytic enzymes such as Luteinizing Hormone, Progesterone, matrix metalloproteinase, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, t-lymphocytes, natural killer t-cells, Antibodies, Antiphospholipid, hla antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, and sICAM?", "What is the association between endometriosis and the following biomarkers: Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, antibodies against antiphospholipids, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, cytokines, interleukins, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, and sICAM, among others, in the context of altered immune cells, soluble adhesion molecules, microRNAs, and urinary or serum markers, and how do these biomarkers correlate with endometrial and thyroid markers, progesterone receptors, and microarray or genomic markers?", "What biomarkers are associated with endometriosis? Specifically, what is the relationship between luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, follistatin, intercellular adhesion molecules, selectins, T lymphocytes, natural killer T cells, antibodies, antiphospholipid, HLA antigens, integrins, cysteine-rich protein 61, vascular endothelial growth factor A, vitamin D-binding protein, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, sICAM, anti-Thomsen Friedenreich antigen, endometrial marker, cell adhesion molecule, cysteine-rich heparin-binding protein, hepatocyte growth factor, serum placental protein, urinary VDBP corrected for creatinine expression, anti-endometrial, cytokeratin-19, anti-thyroid, selectins, progesterone receptor, MTMMP, TIMP, immune cells alteration, soluble intercellular adhesion, MMP, osteopontin, VDBP-Cr, urinary marker, sVCAM,", "What are the biomarkers, cytokines, growth factors, and immune cells alterations associated with endometriosis? Specifically, what is the role of Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, antibodies, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, CAMs, sICAM, Anti-Thomsen Friedenreich antigen, endometrial markers, cell adhesion molecules, cysteine-rich heparin-binding proteins, hepatocyte growth factor, serum placental proteins, urinary VDBP corrected for creatinine expression, anti-endometrial antibodies, cytokeratin-19, anti-thyroid antibodies, selectins, progesterone receptor, MTMMP, TIMP, sVCAM, antiphospholipids, soluble adhesion molecules, micro", "What is the association between Endometriosis and the following biomarkers: Luteinizing Hormone, Progesterone, matrix metalloproteinases (1, 2, 3, and 9), tissue inhibitors of metalloproteinases (1 and 2), glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, antibodies against antiphospholipids, HLA antigens (A1 and A2), integrins, cysteine-rich protein 61, vascular endothelial growth factor A, vitamin D-binding protein, cytokines (interleukin-1, interleukin-6, interleukin-8, interleukin-12, interleukin-13), epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, Keratin-19, sICAM, anti-Thomsen Friedenreich antigen, endometrial markers, cell adhesion molecules, cysteine-rich heparin-binding protein, hepatocyte growth factor, serum placental proteins, urinary VDBP corrected for creatinine expression, anti-endometrial antibodies, cytokeratin-19", "What biomarkers and immune cell alterations are associated with endometriosis, and how do they affect the disease?", "What is the association between endometriosis and alterations in luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, intercellular adhesion molecules, selectins, T-lymphocytes, natural killer T-cells, antibodies, HLA antigens, integrins, cysteine-rich protein 61, vascular endothelial growth factor, vitamin D-binding protein, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, sICAM, anti-Thomsen Friedenreich antigen, endometrial markers, cell adhesion molecules, cysteine-rich heparin-binding protein, hepatocyte growth factor, serum placental proteins, urinary VDBP corrected for creatinine expression, anti-endometrial, cytokeratin-19, anti-thyroid, selectins, progesterone receptors, MTMMP, TIMP, immune cells alterations, soluble intercellular adhesion, MMPs, osteopontin, VDBP-Cr, urinary markers, sVCAM, antiphospholipid, soluble adhesion molecules, microRN"]}
{"id": "CD009175", "boolean": "(Pneumonia[mesh:noexp] OR Pneumonia, Bacterial[mesh:noexp] OR Pneumonia, Mycoplasma[mesh:noexp] OR \"m. pneumoniae\"[Text Word] OR mycoplasma pneumon*[Text Word] OR (community-acquired pneumon*[Text Word] OR community acquired pneumon*[Text Word])) AND (Minors[mesh:noexp] OR Pediatrics[mesh] OR Infant[mesh] OR Child[mesh] OR Schools[mesh] OR Adolescent[mesh:noexp] OR Puberty[mesh:noexp] OR (child*[Text Word] OR schoolchild*[Text Word] OR school age*[Text Word] OR preschool*[Text Word] OR kid[Text Word] OR kids[Text Word] OR toddler*[Text Word]) OR (minor*[Text Word] OR pubert*[Text Word] OR pubescen*[Text Word]) OR (pediatric*[Text Word] OR paediatric*[Text Word]) OR (infant*[Text Word] OR infancy[Text Word] OR newborn*[Text Word] OR baby*[Text Word] OR babies[Text Word] OR neonat*[Text Word] OR preterm*[Text Word] OR prematur*[Text Word]) OR (nursery school*[Text Word] OR kindergar*[Text Word] OR primary school*[Text Word] OR secondary school*[Text Word] OR elementary school*[Text Word] OR high school*[Text Word] OR highschool*[Text Word]) OR (adoles*[Text Word] OR teen*[Text Word] OR boy*[Text Word] OR girl*[Text Word])) AND (Fever[mesh:noexp] OR Exanthema[mesh:noexp] OR Cough[mesh:noexp] OR Diarrhea[mesh] OR Headache[mesh:noexp] OR \"shortness of breath\"[Text Word] OR clinical feature*[Text Word] OR wheez*[Text Word] OR \"chest pain\"[Text Word] OR headache*[Text Word] OR myalgia[Text Word] OR coryza[Text Word] OR fever*[Text Word] OR clinical assessment*[Text Word] OR cough*[Text Word] OR sore throat*[Text Word] OR crepitation*[Text Word] OR (symptom*[Text Word] OR sign*[Text Word] OR characteristic*[Text Word] OR manifestation*[Text Word]) OR (diarrhoea[Text Word] OR diarrhea[Text Word]) OR (rash[Text Word] OR rashes[Text Word]))", "generated_query": ["What is the association between pneumonia, bacterial or mycoplasma, and clinical features such as fever, cough, diarrhea, headache, shortness of breath, chest pain, myalgia, coryza, sore throat, and rash in minors, pediatrics, infants, children, schools, adolescents, and puberty?", "What is the association between pneumonia (including bacterial and mycoplasma), and clinical features such as fever, cough, shortness of breath, headache, chest pain, myalgia, sore throat, crepitation, and diarrhea in pediatric populations (including minors, infants, children, schools, adolescents, and puberty)?", "What is the impact of pneumonia, including bacterial and mycoplasma pneumoniae, on minors and children, including infants, toddlers, preschoolers, school-age children, and adolescents, as evidenced by clinical features such as fever, cough, exanthema, diarrhea, headache, shortness of breath, wheezing, chest pain, myalgia, coryza, sore throat, and crepitations? Relevant documents should include studies on clinical assessment, symptoms, signs, and manifestations, as well as studies on nursery schools, kindergartens, primary and secondary schools, and high schools.", "What is the prevalence and clinical presentation of pneumonia caused by bacterial or mycoplasma infections in minors, pediatrics, infants, children, schools, adolescents, and puberty, including those in nursery, kindergarten, primary, secondary, and elementary schools, and high school, with symptoms such as fever, exanthema, cough, diarrhea, headache, shortness of breath, wheezing, chest pain, myalgia, and sore throat?", "What is the association between community-acquired pneumonia caused by bacteria or mycoplasma and clinical features such as fever, cough, shortness of breath, chest pain, headache, myalgia, sore throat, diarrhea, and rash in pediatric patients including infants, children, and adolescents attending schools or daycare centers?", "What is the effectiveness of interventions for pneumonia, bacterial pneumonia, and Mycoplasma pneumonia in infants, children, and adolescents presenting with fever, exanthema, cough, diarrhea, headache, shortness of breath, wheezing, chest pain, myalgia, coryza, sore throat, crepitation, or rash in school or nursery settings, as measured by clinical features, assessments, symptoms, or signs?", "What is the association between pneumonia in minors, including infants, children, adolescents, and those attending schools, and clinical features such as fever, cough, shortness of breath, and diarrhea, as well as other symptoms and signs such as headache, chest pain, myalgia, and rashes? This query should also include bacteria that cause pneumonia, such as Mycoplasma and community-acquired pneumonia. The query should retrieve all relevant studies and articles related to the topic from a semantic-based search engine.", "What is the impact of pneumonia on minors and pediatric populations, including infants, school-aged children, adolescents, and those in nursery or kindergarten? Specifically, what are the clinical features and symptoms, such as fever, cough, exanthema, and shortness of breath, associated with bacterial pneumonia, Mycoplasma pneumoniae, and community-acquired pneumonia in these populations?", "What is the relationship between pneumonia and its bacterial and mycoplasma types, and minors, pediatrics, infants, children, schools, adolescents, puberty, and clinical features such as fever, exanthema, cough, diarrhea, headache, shortness of breath, wheezing, chest pain, myalgia, coryza, sore throat, and rash?", "What is the prevalence and clinical presentation of pneumonia caused by bacterial and mycoplasma infections in children and adolescents attending schools or childcare centers? Specifically, I am interested in fever, cough, shortness of breath, chest pain, headache, myalgia, exanthema, and diarrhea as clinical features in this population."]}
{"id": "CD010296", "boolean": "(Aortic Aneurysm[mesh] OR Aorta, Abdominal[mesh:noexp] OR AAA*[All Fields] OR (EVAR[All Fields] OR TEVAR[All Fields] OR EVRAR[All Fields]) OR (abdom*[All Fields] AND aneurysm*[All Fields]) OR (aort*[All Fields] AND aneurysm*[All Fields]) OR (abdom*[All Fields] AND aort*[All Fields]) OR (aort*[All Fields] AND morphol*[All Fields])) AND (ultrasonography, Doppler, color[mesh:noexp] OR ultrasonography, Doppler, duplex[mesh:noexp] OR ultrasonography[mesh:noexp] OR ultrasonography, Doppler, pulsed[mesh:noexp] OR ultrasonics[mesh:noexp] OR ultrasonography[mesh:noexp] OR ultrasonic imaging[All Fields] OR sonograph*[All Fields] OR ultrasound[All Fields] OR echograph*[All Fields] OR sonogram*[All Fields] OR ultrasonogra*[All Fields] OR (USS[All Fields] OR DUS[All Fields] OR CDUS[All Fields] OR CEUS[All Fields]) OR (doppler[All Fields] OR duplex[All Fields]) OR (contrast[All Fields] AND US[All Fields])) AND (postoperative complications[mesh:noexp] OR prosthesis failure[mesh:noexp] OR anastomotic leak[mesh:noexp] OR surveillance[All Fields] OR postoperative[All Fields] OR outcome[All Fields] OR evaluat*[All Fields] OR perigraft leak*[All Fields] OR follow-up[All Fields] OR effecti*[All Fields] OR perigraft flow[All Fields] OR (endoleak*[All Fields] OR endotension[All Fields])) AND (Blood Vessel Prosthesis[mesh:noexp] OR Blood Vessel Prosthesis Implantation[mesh:noexp] OR Endovascular Procedures[mesh:noexp] OR stents[mesh] OR stent*[All Fields] OR graft*[All Fields] OR endograft*[All Fields] OR endovascular[All Fields] OR endoluminal*[All Fields] OR endoprosthe*[All Fields] OR prosthe*[All Fields])", "generated_query": ["What is the effectiveness of different imaging techniques in the postoperative surveillance of patients with aortic aneurysms treated with endovascular procedures, stents, grafts, or endografts? Specifically, how do Doppler ultrasound, color duplex ultrasound, pulsed ultrasound, contrast ultrasound, and other sonographic imaging techniques compare in detecting postoperative complications such as prosthesis failure, anastomotic leak, endoleaks, endotension, perigraft leaks, perigraft flow, and other adverse outcomes?", "What is the effectiveness of ultrasound imaging and endovascular procedures using blood vessel prostheses, stents, and grafts in evaluating postoperative complications, outcomes, and surveillance for patients with aortic aneurysms or abdominal aortic aneurysms treated with EVAR, TEVAR, or EVRAR, and how do perigraft flow and endoleak contribute to potential complications?", "Can ultrasound imaging techniques accurately detect and monitor postoperative complications and outcomes in patients with aortic aneurysm who have undergone endovascular procedures using blood vessel prostheses such as stents, grafts, and endografts?", "What is the effectiveness of ultrasonography, Doppler, color, duplex, pulsed, and contrast imaging techniques in the surveillance and follow-up of patients with postoperative complications, prosthesis failure, anastomotic leak, endoleak, endotension, perigraft leak, perigraft flow, and other outcomes after Blood Vessel Prosthesis Implantation, Endovascular Procedures, or the use of stents, grafts, endografts, endoprostheses, or prostheses in the treatment of Aortic Aneurysm, Aorta Abdominal, and related conditions?", "What is the effectiveness of ultrasonography, Doppler, color, or duplex imaging for surveillance and evaluation of postoperative complications, such as anastomotic leak, perigraft flow, and endoleak, after endovascular procedures using blood vessel prostheses, stents, grafts, or endoprostheses in patients with aortic aneurysm or abdominal aorta?", "What is the efficacy of ultrasonography (including Doppler, color, duplex, and pulsed) and other imaging techniques (such as ultrasound, echography, and sonography) in detecting postoperative complications (such as anastomotic leak and prosthesis failure) and monitoring outcomes (such as perigraft flow and endoleak) in patients who have undergone endovascular procedures for aortic aneurysm repair using stents, grafts, endografts, or other types of prostheses?", "What are the postoperative complications and outcomes of using ultrasonography, Doppler, and other imaging techniques to evaluate the effectiveness of blood vessel prostheses, including stents, grafts, and endografts, in treating aortic aneurysms and abdominal aortic aneurysms?", "What is the effectiveness of using ultrasonography, Doppler, color or duplex, pulsed ultrasonography, or other types of ultrasonic imaging in the surveillance, evaluation, and follow-up of postoperative complications such as prosthesis failure, anastomotic leak, perigraft leak, endoleak, and endotension in patients with aortic aneurysm or aortic abdominal pathology who underwent endovascular procedures using stents, grafts, endografts, or other prostheses?", "What is the effectiveness of using Doppler ultrasonography, contrast-enhanced ultrasonography, or other ultrasound imaging techniques in the evaluation and surveillance of postoperative complications, prosthesis failure, anastomotic leaks, and endoleaks after endovascular repair of abdominal aortic aneurysms using blood vessel prostheses, stents, or endografts?", "What are the postoperative complications and outcomes associated with ultrasonography techniques, such as color Doppler, duplex, and pulsed, for surveillance and evaluation of abdominal aortic aneurysms treated with endovascular procedures such as stenting, grafting, and endoprostheses?"]}
{"id": "CD010680", "boolean": "(Oscillometry[mesh:noexp] OR Ankle Brachial Index[mesh:noexp] OR Blood Pressure Determination[mesh:noexp] OR Laser-Doppler Flowmetry[mesh:noexp] OR AAI[Title/Abstract] OR oscillometr*[Title/Abstract] OR ABPI[Title/Abstract] OR ABI[Title/Abstract] OR (doppler[Title/Abstract] AND (ultrasound[Title/Abstract] OR flow*[Title/Abstract] OR method[Title/Abstract] OR device[Title/Abstract])) OR (BP[Title/Abstract] AND ratio[Title/Abstract]) OR (ankle[Title/Abstract] AND index[Title/Abstract]) OR (four[Title/Abstract] AND limbs[Title/Abstract] AND pressure[Title/Abstract]) OR (arm[Title/Abstract] AND index[Title/Abstract]) OR (brachial[Title/Abstract] AND (index[Title/Abstract] OR pressure[Title/Abstract])) OR (systolic[Title/Abstract] AND ratio[Title/Abstract]) OR (pressure[Title/Abstract] AND ratio[Title/Abstract])) AND (Peripheral Vascular Diseases[mesh] OR Arterial Occlusive Diseases[mesh:noexp] OR Arteriosclerosis[mesh] OR Atherosclerosis[mesh] OR Peripheral Arterial Disease[mesh] OR Intermittent Claudication[mesh:noexp] OR CLI[Title/Abstract] OR dysvascular*[Title/Abstract] OR arteriopathic[Title/Abstract] OR (atherosclero*[Title/Abstract] OR arteriosclero*[Title/Abstract] OR PVD[Title/Abstract] OR PAOD[Title/Abstract] OR PAD[Title/Abstract]) OR (veno*[Title/Abstract] AND (occlus*[Title/Abstract] OR steno*[Title/Abstract] OR obstruct*[Title/Abstract] OR lesio*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (arter*[Title/Abstract] AND (occlus*[Title/Abstract] OR steno*[Title/Abstract] OR obstruct*[Title/Abstract] OR lesio*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (leg[Title/Abstract] AND (obstruct*[Title/Abstract] OR occlus*[Title/Abstract] OR steno*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (limb[Title/Abstract] AND (obstruct*[Title/Abstract] OR occlus*[Title/Abstract] OR steno*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (vein*[Title/Abstract] AND (occlus*[Title/Abstract] OR steno*[Title/Abstract] OR obstruct*[Title/Abstract] OR lesio*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (peripher*[Title/Abstract] AND (occlus*[Title/Abstract] OR steno*[Title/Abstract] OR obstruct*[Title/Abstract] OR lesio*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (peripheral[Title/Abstract] AND dis*[Title/Abstract]) OR (claudic*[Title/Abstract] OR hinken*[Title/Abstract] OR IC[Title/Abstract]) OR (vascular[Title/Abstract] AND (occlus*[Title/Abstract] OR steno*[Title/Abstract] OR obstruct*[Title/Abstract] OR lesio*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])) OR (lower[Title/Abstract] AND extrem*[Title/Abstract] AND (obstruct*[Title/Abstract] OR occlus*[Title/Abstract] OR steno*[Title/Abstract] OR block*[Title/Abstract] OR obliter*[Title/Abstract])))", "generated_query": ["What is the effectiveness of oscillometry, ankle-brachial index, blood pressure determination, laser-Doppler flowmetry, AAI, ABPI, and Doppler ultrasound in diagnosing peripheral vascular diseases, arterial occlusive diseases, arteriosclerosis, atherosclerosis, peripheral arterial disease, intermittent claudication, CLI, dysvascular conditions, and arteriopathic conditions?", "What is the diagnostic accuracy of oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, and other related methods in detecting peripheral vascular diseases such as arterial occlusive diseases, arteriosclerosis, atherosclerosis, peripheral arterial disease, and intermittent claudication?", "What methods can be used to diagnose and monitor peripheral vascular diseases such as arterial occlusive diseases, atherosclerosis, and peripheral arterial disease? Specifically, how effective are oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, AAI, and doppler ultrasound in detecting and tracking these conditions? Additionally, what are the most common symptoms and risk factors associated with these conditions, including intermittent claudication, dysvascularity, and arteriopathy?", "What is the effectiveness of oscillometry, ankle brachial index, blood pressure determination, laser-doppler flowmetry, AAI, ABPI, ABI, doppler ultrasound, and arm/leg pressure ratio in diagnosing and managing peripheral vascular diseases, including arterial occlusive diseases, arteriosclerosis, atherosclerosis, peripheral arterial disease, intermittent claudication, dysvascular and arteriopathic conditions, and obstruction or stenosis in veins, arteries, and peripheral vessels?", "What are the most effective methods for assessing peripheral vascular diseases, including arterial occlusive diseases, arteriosclerosis, atherosclerosis, intermittent claudication, and peripheral arterial disease, using techniques such as oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, and Doppler ultrasound?", "What diagnostic tests and techniques can effectively evaluate peripheral arterial disease, arteriosclerosis, and arterial occlusive diseases?", "What are the most effective methods for diagnosing and assessing peripheral vascular diseases, arterial occlusive diseases, arteriosclerosis, atherosclerosis, and peripheral arterial disease? Specifically, can oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, AAI, ABPI, ABI, Doppler ultrasound, and limb pressure ratios accurately diagnose and assess these conditions? Additionally, can these methods be used to diagnose and assess CLI, dysvascular conditions, arteriopathic conditions, venous and arterial obstructions, leg and limb obstructions, peripheral vascular disease, and intermittent claudication?", "What are the most effective non-invasive diagnostic tools for assessing peripheral vascular diseases, including arterial occlusive diseases, arteriosclerosis, atherosclerosis, peripheral arterial disease, and intermittent claudication? Specifically, I am interested in studies that investigate the use of oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, or Doppler ultrasound with flow measurement methods for assessing these conditions.", "What diagnostic methods and tools are effective in identifying and diagnosing peripheral vascular diseases such as arterial occlusive diseases, arteriosclerosis, atherosclerosis, peripheral arterial disease, intermittent claudication, CLI, and dysvascular conditions, using parameters such as oscillometry, ankle brachial index, blood pressure determination, laser-Doppler flowmetry, and AAI, as well as relevant keywords such as doppler, ultrasound, flow, method, device, ratio, arm, brachial, systolic, pressure, atherosclero*, arteriosclero*, PVD, PAOD, PAD, veno*, arter*, leg, limb, vein*, peripher*, peripheral, claudic*, hinken*, IC, vascular, lower extrem*, and obstruct*, occlus*, steno*, block*, lesio*, and obliter*?", "What is the association between non-invasive peripheral vascular testing methods, such as oscillometry, ankle-brachial index, laser-Doppler flowmetry, and blood pressure determination, and peripheral vascular diseases including arterial occlusive diseases, atherosclerosis, peripheral arterial disease, and intermittent claudication, as well as related terms like PVD, PAD, and CLI, among others?"]}
{"id": "CD012083", "boolean": "(Ultrasonography[mesh] OR ultrason*[All Fields] OR ultrasound*[All Fields] OR echotomograph*[All Fields] OR echo tomograph*[All Fields] OR echograph*[All Fields] OR sonograph*[All Fields] OR ultra sound[All Fields] OR acoustic[All Fields]) AND (Intubation, Gastrointestinal[mesh] OR (stomach[All Fields] OR gastric[All Fields] OR gastro*[All Fields] OR nasogastric[All Fields] OR feeding[All Fields] OR fine bore[All Fields] OR Ryles[All Fields]) AND (tube*[All Fields] OR intubat*[All Fields]))", "generated_query": ["What is the effectiveness of ultrasonography, echotomography, echography, sonography, and acoustic imaging techniques in patients undergoing intubation for gastrointestinal reasons such as feeding, nasogastric placement, or Ryles tube insertion?", "\"What is the effectiveness of using ultrasonography, ultrasound technology, or echotomography to guide gastrointestinal intubation in patients with stomach or feeding tube placement needs? Specifically, are there any studies that have investigated the use of these technologies in conjunction with fine bore or Ryles tubes?\"", "What is the effectiveness of ultrasonography, echotomography, sonography, and acoustic techniques in guiding the intubation of gastrointestinal tubes in patients undergoing feeding or stomach-related procedures, including nasogastric and Ryles tube insertion, fine bore feeding, and intubation techniques?", "What is the effectiveness of using ultrasound or echotomography to guide gastrointestinal intubation using fine bore or Ryles tubes in patients requiring enteral feeding?", "What is the effectiveness of ultrasonography, echotomography, echography, and sonography in guiding gastrointestinal intubation, including the use of fine bore, nasogastric, and Ryles tubes?", "What is the effectiveness of using ultrasound technology (including ultrasonography, echotomography, echography, sonography, and acoustic imaging) for guiding and monitoring gastrointestinal intubation procedures, specifically in the stomach (including gastric, nasogastric, feeding, fine bore, and Ryles tubes)?", "What is the effectiveness of ultrasound, echotomography, echograph, and sonography in relation to gastrointestinal intubation, including the use of stomach, gastric, nasogastric, feeding, fine bore, and Ryles tubes?", "What is the efficacy of ultrasonography, echotomography, echography, sonography, and acoustic techniques in detecting and guiding intubation procedures in patients with gastrointestinal conditions, such as those requiring stomach or gastric tubes, nasogastric or fine bore feeding, or Ryles tubes?", "What is the effectiveness of ultrasonography, echotomography, and sonography in detecting and guiding placement of gastrointestinal intubation tubes, including fine bore and Ryles tubes, in patients with stomach or gastric feeding needs?", "What is the effectiveness of using ultrasonography, echotomography, echography, or sonography in conjunction with intubation of the gastrointestinal tract through methods such as nasogastric feeding, fine bore, or Ryles tube insertion in the stomach or gastric region?"]}
{"id": "CD012216", "boolean": "(AMYViD[tiab] OR amyvid*[tiab] OR Florbetapir[tiab] OR \"florbetapir-fluorine-18\u201d[tiab] OR \"18F-AV-45\u201d[tiab] or \"(18)F-AV-45\"[tiab] or \"[18F]AV-45\"[tiab] or \"[(18)F]AV-45\"[tiab] OR \"[18F]Florbetapir\u201d[tiab] OR \"florbetapir-PET\u201d[tiab]) OR ((Fluorine Radioisotopes[MeSH Terms] OR Aniline Compounds[MeSH Terms] OR Ethylene Glycols[MeSH Terms] OR Stilbenes[MeSH Terms] OR Radioligand Assay[MeSH Terms] OR radioligand[tiab]) AND (Alzheimer Disease[MeSH Terms] OR Plaque, Amyloid[MeSH Terms])) AND (1946/01/01:2017/05/01[Publication Date])", "generated_query": ["What is the effectiveness of Amyvid, Florbetapir, and related compounds in diagnosing Alzheimer's disease, as measured by radioligand assays, in studies published between 1946 and May 2017?", "What is the effectiveness of Florbetapir or Amyvid, including related terms such as \"florbetapir-fluorine-18\", \"18F-AV-45\", \"[(18)F]AV-45\", and \"[18F]Florbetapir\", as well as relevant MeSH terms such as Fluorine Radioisotopes, Aniline Compounds, Ethylene Glycols, Stilbenes, Radioligand Assay, and amyloid plaque, in the diagnosis or detection of Alzheimer's disease, limited to publications from January 1946 to May 2017?", "What is the evidence for the use of Amyvid, Florbetapir, or related radioligand assays, combined with Fluorine radioisotopes, Aniline compounds, Ethylene glycols, or Stilbenes, in the diagnosis or evaluation of Alzheimer's Disease and Amyloid Plaque, from 1946 to 2017?", "What is the effectiveness of amyloid imaging agents such as AMYViD, florbetapir-fluorine-18, and 18F-AV-45 in the detection of Alzheimer's disease plaques using radioligand assays, fluorine radioisotopes, aniline compounds, ethylene glycols, and stilbenes as indicators, from publications between 1946/01/01 and 2017/05/01?", "What is the evidence for the use of AmyViD, Florbetapir, 18F-AV-45, or 18F-Florbetapir-PET as radioligands in detecting Alzheimer's disease amyloid plaque, as well as their efficacy in discriminating Alzheimer's disease from other conditions? The search should cover studies published from 1946 to May 2017.", "What is the efficacy of Amyvid, florbetapir, or related radioligands labeled with fluorine-18 in detecting amyloid plaques in Alzheimer's disease patients from 1946 to 2017?", "What is the effectiveness of Florbetapir and related radioligands in detecting Alzheimer's Disease amyloid plaques as measured by PET imaging, and what is the evidence for their use from studies published between 1946 and May 2017?", "What is the efficacy of amyloid PET imaging using amyvid, florbetapir, or [18F]AV-45, in detecting Alzheimer's disease in patients with amyloid plaque pathology, as compared to radioligand assays, and how does it affect clinical decision-making? (Search period: 1946/01/01 - 2017/05/01)", "What is the effectiveness of Amyvid, Florbetapir, 18F-AV-45, and related radioligand assays for detecting amyloid plaques in patients with Alzheimer's disease from 1946 to 2017?", "\"Retrieve all relevant documents related to the use of Amyvid, Florbetapir, and radioligand assays in the detection of Alzheimer's disease plaques, using fluorine radioisotopes, aniline compounds, ethylene glycols, and stilbenes, published between 1946 and May 2017.\""]}
{"id": "CD010864", "boolean": "(Pulmonary Embolism[mesh] OR (pulmonary[Title/Abstract] AND embol*[Title/Abstract]) OR (pulmonary[Title/Abstract] AND thrombo*[Title/Abstract]) OR (lung[Title/Abstract] AND embol*[Title/Abstract]) OR (lung[Title/Abstract] AND thrombo*[Title/Abstract]) OR (PE[Title/Abstract] OR PTE[Title/Abstract])) AND (Enzyme-Linked Immunosorbent Assay[mesh:noexp] OR Biological Markers[mesh:noexp] OR \"Nephelometry and Turbidimetry\"[mesh:noexp] OR Fibrin Fibrinogen Degradation Products[mesh:noexp] OR elfa*[Title/Abstract] OR NycoCard[Title/Abstract] OR \"Instant I.A\"[Title/Abstract] OR Enzygnost[Title/Abstract] OR stratus[Title/Abstract] OR turbidimetr*[Title/Abstract] OR Minutex[Title/Abstract] OR Asserachrom[Title/Abstract] OR dimeri*[Title/Abstract] OR SimpliRed[Title/Abstract] OR LIATEST[Title/Abstract] OR HemosIL[Title/Abstract] OR blood agglutination[Title/Abstract] OR TriniLIZE[Title/Abstract] OR Dimertest[Title/Abstract] OR Vidas[Title/Abstract] OR Fibrinostika[Title/Abstract] OR elisa*[Title/Abstract] OR \"BC DD\"[Title/Abstract] OR biopool[Title/Abstract] OR FDP[Title/Abstract] OR d-dimer[Title/Abstract] OR Turbiquant[Title/Abstract] OR Innovance-DD[Title/Abstract] OR enzyme linked[Title/Abstract] OR latex agglutination[Title/Abstract] OR Immunoturbidimetr*[Title/Abstract] OR TintElize[Title/Abstract] OR (fibrin[Title/Abstract] AND d[Title/Abstract]) OR (Tinaquant[Title/Abstract] OR Tina-quant[Title/Abstract]) OR (LPIA[Title/Abstract] OR EIA[Title/Abstract]) OR (latex[Title/Abstract] AND assay*[Title/Abstract]) OR (\"IL test\"[Title/Abstract] OR IL-DD[Title/Abstract]))", "generated_query": ["What are the most effective diagnostic tests for pulmonary embolism and thrombosis, including Enzyme-Linked Immunosorbent Assay, Biological Markers, and other assays such as NycoCard, d-dimer, and latex agglutination, in addition to any relevant mesh terms or title/abstract keywords?", "What is the diagnostic accuracy of Enzyme-Linked Immunosorbent Assay (ELISA), Biological Markers, Nephelometry and Turbidimetry, and other related assays in detecting Pulmonary Embolism or Thromboembolism in patients with lung-related symptoms?", "What are the most accurate diagnostic markers for pulmonary embolism, including Enzyme-Linked Immunosorbent Assay, Biological Markers, Nephelometry and Turbidimetry, Fibrin Fibrinogen Degradation Products, elfa*, NycoCard, Instant I.A, Enzygnost, stratus, turbidimetr*, Minutex, Asserachrom, dimeri*, SimpliRed, LIATEST, HemosIL, blood agglutination, TriniLIZE, Dimertest, Vidas, Fibrinostika, elisa*, BC DD, biopool, FDP, d-dimer, Turbiquant, Innovance-DD, enzyme linked, latex agglutination, Immunoturbidimetr*, TintElize, fibrin d, Tinaquant, Tina-quant, LPIA, EIA, latex assay*, and IL test?", "What are the most reliable enzyme-linked immunosorbent assay (ELISA) and biological marker tests for diagnosing pulmonary embolism (PE)? Additionally, what are the alternative diagnostic methods to ELISA and biological markers, such as nephelometry and turbidimetry, fibrin fibrinogen degradation products, elfa*, NycoCard, Instant I.A, Enzygnost, stratus, turbidimetr*, Minutex, Asserachrom, dimeri*, SimpliRed, LIATEST, HemosIL, blood agglutination, TriniLIZE, Dimertest, Vidas, Fibrinostika, elisa*, BC DD, biopool, FDP, d-dimer, Turbiquant, Innovance-DD, enzyme linked, latex agglutination, Immunoturbidimetr*, TintElize, fibrin d, Tinaquant, Tina-quant, LPIA, EIA, latex assay*, IL test, and IL-DD, for diagnosing PE?", "What are the most effective diagnostic assays for detecting pulmonary embolism, including ELISA, biological markers, nephelometry, and turbidimetry?", "What are the best assays or biological markers to diagnose pulmonary embolism, including ELISA, nephelometry, and turbidimetry, in addition to other methods like enzyme linked, latex agglutination, and immunoturbidimetry, among others?", "What is the diagnostic accuracy of Enzyme-Linked Immunosorbent Assay, Biological Markers, Nephelometry and Turbidimetry, Fibrin Fibrinogen Degradation Products, elfa*, NycoCard, Instant I.A, Enzygnost, stratus, turbidimetr*, Minutex, Asserachrom, dimeri*, SimpliRed, LIATEST, HemosIL, blood agglutination, TriniLIZE, Dimertest, Vidas, Fibrinostika, elisa*, BC DD, biopool, FDP, d-dimer, Turbiquant, Innovance-DD, enzyme linked, latex agglutination, Immunoturbidimetr*, TintElize, fibrin d, Tinaquant, Tina-quant, LPIA, EIA, latex assay*, and IL-DD in detecting Pulmonary Embolism and related terms (pulmonary and embol* or thrombo*)?", "What is the diagnostic accuracy of Enzyme-Linked Immunosorbent Assay, Biological Markers, Nephelometry and Turbidimetry, and other relevant assays in detecting Pulmonary Embolism or Thromboembolism in patients with suspected or confirmed PE or PTE?", "What is the effectiveness of enzyme-linked immunosorbent assay, biological markers, nephelometry and turbidimetry, fibrin fibrinogen degradation products, and other related diagnostic tests in detecting pulmonary embolism or thrombosis in the lung, as well as PE and PTE, based on systematic reviews and relevant studies?", "What are the most reliable diagnostic markers for pulmonary embolism, including Enzyme-Linked Immunosorbent Assay, biological markers, nephelometry, turbidimetry, fibrin fibrinogen degradation products, elfa, NycoCard, Instant I.A, Enzygnost, stratus, turbidimetry, Minutex, Asserachrom, dimeri, SimpliRed, LIATEST, HemosIL, blood agglutination, TriniLIZE, Dimertest, Vidas, Fibrinostika, elisa, BC DD, biopool, FDP, d-dimer, Turbiquant, Innovance-DD, enzyme linked, latex agglutination, Immunoturbidimetry, TintElize, fibrin and d-dimer, Tinaquant, Tina-quant, LPIA, EIA, latex assay, and IL test-DD?"]}
{"id": "CD008122", "boolean": "(Malaria[mesh] OR Plasmodium[mesh] OR Malaria[Title/Abstract]) AND (Reagent kits, diagnostic[mesh] OR immunoassay[mesh:noexp] OR chromatography[mesh:noexp] OR Enzyme-linked immunosorbent assay[mesh:noexp] OR rapid diagnos* test*[Title/Abstract] OR RDT[Title/Abstract] OR Dipstick*[Title/Abstract] OR Rapid diagnos* device*[Title/Abstract] OR MRDD[Title/Abstract] OR OptiMal[Title/Abstract] OR Binax NOW[Title/Abstract] OR ParaSight[Title/Abstract] OR Immunochromatograph*[Title/Abstract] OR Antigen detection method*[Title/Abstract] OR Rapid malaria antigen test*[Title/Abstract] OR Combo card test*[Title/Abstract] OR Rapid test*[Title/Abstract] OR Card test*[Title/Abstract] OR (Rapid[All Fields] AND (detection*[Title/Abstract] OR diagnos*[Title/Abstract]))", "generated_query": ["What is the efficacy of reagent kits, immunoassays, chromatography, and other diagnostic tests such as Enzyme-linked immunosorbent assays, rapid diagnostic tests, Dipsticks, and Rapid diagnostic devices for the detection and diagnosis of Malaria or Plasmodium infection?", "What is the diagnostic accuracy of reagent kits, immunoassays, chromatography, and other rapid diagnostic tests for detecting malaria caused by Plasmodium or other species?", "What is the efficacy of reagent kits, diagnostic tests, immunoassays, chromatography, enzyme-linked immunosorbent assays, and rapid diagnostic tests such as dipsticks, MRDD, OptiMal, Binax NOW, ParaSight, immunochromatography, and antigen detection methods, for detecting malaria caused by Plasmodium or described as Malaria in the title or abstract? Additionally, are rapid detection or diagnostic tests effective for diagnosing malaria?", "What are the most effective reagent kits, diagnostic immunoassays, and chromatography tests for detecting malaria caused by Plasmodium, as well as rapid diagnostic tests such as RDT, dipsticks, MRDD, OptiMal, Binax NOW, ParaSight, immunochromatography, antigen detection methods, combo card tests, and rapid tests for malaria detection? Additionally, how do these tests compare to each other in terms of accuracy and effectiveness?", "What is the accuracy of various diagnostic methods, such as reagent kits, immunoassays, chromatography, enzyme-linked immunosorbent assay, and rapid tests, for detecting malaria caused by Plasmodium and other strains, including the use of Dipstick, MRDD, OptiMal, Binax NOW, ParaSight, immunochromatography, and antigen detection methods, as well as combo card tests, card tests, and other rapid detection and diagnosis methods?", "What are the most effective diagnostic methods for malaria caused by Plasmodium, including reagent kits, immunoassays, chromatography, ELISA, rapid diagnostic tests such as dipsticks and devices, MRDD, OptiMal, Binax NOW, ParaSight, immunochromatography, antigen detection methods, combo card tests, and rapid card tests that involve detection or diagnosis?", "What is the effectiveness of reagent kits, immunoassays, and chromatography in diagnosing malaria or Plasmodium, including rapid diagnosis tests such as Dipstick and OptiMal?", "What is the diagnostic accuracy of various rapid diagnostic tests, including immunoassay, chromatography, enzyme-linked immunosorbent assay, and rapid diagnostic devices, for detecting malaria or Plasmodium, as compared to reagent kits or antigen detection methods, based on studies using OptiMal, Binax NOW, ParaSight, Immunochromatography, rapid malaria antigen tests, combo card tests, or card tests? Additionally, does the inclusion of the term \"rapid\" and \"detection\" or \"diagnosis\" impact the search results?", "What is the diagnostic accuracy of reagent kits, immunoassays, and other diagnostic methods for detecting malaria caused by Plasmodium or other parasites, including rapid diagnostic tests, dipsticks, and enzyme-linked immunosorbent assays?", "What is the diagnostic accuracy of various methods, such as reagent kits, immunoassays, chromatography, enzyme-linked immunosorbent assays, rapid diagnostic tests, dipsticks, and rapid diagnostic devices, for detecting malaria caused by Plasmodium or other sources, as indicated by studies including OptiMal, Binax NOW, ParaSight, immunochromatography, antigen detection, combo card tests, rapid tests, and card tests? Additionally, how effective are rapid detection and diagnosis techniques in identifying malaria, according to studies using these approaches?"]}
{"id": "CD010213", "boolean": "(Elasticity Imaging Techniques[mesh] OR elastogr*[Title/Abstract] OR sonoelastogr*[Title/Abstract] OR acoustogra*[Title/Abstract]) AND (Pancreatic Neoplasms[mesh] OR Pancreatitis, Chronic[mesh] OR Pancreatic Cyst[mesh] OR Pancreas[mesh] OR pancreas[Title/Abstract] OR pancreatic[Title/Abstract]) AND (Ultrasonography[mesh] OR echogra*[Title/Abstract] OR ultrason*[Title/Abstract] OR ultrasound[Title/Abstract]) AND (Endosonography[mesh] OR endosonogra*[Title/Abstract] OR EUS[Title/Abstract]) AND (Tomography, X-Ray Computed[mesh] OR Positron-Emission Tomography[mesh:noexp] OR Magnetic Resonance Imaging[mesh] OR CT[Title/Abstract] OR tomodensitometry[Title/Abstract] OR PET[Title/Abstract] OR MRI[Title/Abstract] OR NMRI[Title/Abstract] OR zeugmatogra*[Title/Abstract] OR ((computed[Title/Abstract] OR computerised[Title/Abstract] OR computerized[Title/Abstract] OR emission[Title/Abstract] OR positron[Title/Abstract] OR magneti*[Title/Abstract] OR MR[Title/Abstract] OR NMR[Title/Abstract] OR proton[Title/Abstract] OR acoustic[Title/Abstract] OR ARFI[Title/Abstract]) AND (tomogra*[Title/Abstract] OR scan[Title/Abstract] OR scans[Title/Abstract] OR imaging[Title/Abstract]))) AND (Endoscopy, Gastrointestinal[mesh] OR endoscop*[Title/Abstract])", "generated_query": ["What are the diagnostic capabilities of various elasticity imaging techniques such as elastography, sonoelastography, and acoustography in detecting pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and pancreatic diseases in general, when used in conjunction with ultrasonography, endosonography, computed tomography, positron-emission tomography, magnetic resonance imaging, and gastrointestinal endoscopy?", "What is the efficacy of elasticity imaging techniques, including elastography, sonoelastography, and acoustography, combined with ultrasonography, endosonography, and various imaging modalities such as CT, PET, and MRI, in the diagnosis and management of pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic diseases? Are there any benefits of combining these techniques with gastrointestinal endoscopy?", "What is the effectiveness of elasticity imaging techniques, including elastography, sonoelastography, and acoustography, in detecting pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic diseases, using ultrasonography, endosonography, computed tomography, magnetic resonance imaging, and positron emission tomography, in combination with gastrointestinal endoscopy?", "What is the efficacy of elasticity imaging techniques, including sonoelastography and acoustography, in the diagnosis of pancreatic neoplasms, chronic pancreatitis, and pancreatic cysts? How do ultrasonography and endosonography, along with computed tomography, magnetic resonance imaging, and positron-emission tomography, compare in their accuracy for detecting these conditions? Additionally, how does endoscopy, particularly gastrointestinal endoscopy, factor into the diagnosis of these pancreatic diseases?", "What is the effectiveness of using Elasticity Imaging Techniques, Elastography, Sonoelastography, and Acoustography in conjunction with Ultrasonography, Endosonography, and Computed Tomography, Positron-Emission Tomography, and Magnetic Resonance Imaging for the detection and diagnosis of pancreatic neoplasms, chronic pancreatitis, pancreatic cyst, and pancreatic diseases in general, when combined with gastrointestinal endoscopy?", "What is the efficacy of elasticity imaging techniques, including sonoelastography and acoustography, in detecting pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic abnormalities, using ultrasonography, endosonography, computed tomography, magnetic resonance imaging, and gastrointestinal endoscopy?", "What is the diagnostic performance of Elasticity Imaging Techniques, elastography, sonoelastography, and acoustography in the detection and differentiation of pancreatic neoplasms, chronic pancreatitis, and pancreatic cysts as compared to Ultrasonography, echography, ultrasound, and Endosonography, as well as Tomography, X-Ray Computed, Positron-Emission Tomography, Magnetic Resonance Imaging, and Endoscopy in patients with pancreatic disorders?", "What is the diagnostic value of elasticity imaging techniques (including sonoelastography and acoustography) in detecting pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic abnormalities, as evaluated by ultrasound, endosonography, computed tomography, positron-emission tomography, magnetic resonance imaging, or gastrointestinal endoscopy?", "What is the effectiveness of elasticity imaging techniques, including elastography, sonoelastography, and acoustography, combined with ultrasonography, endosonography, and various imaging modalities such as computed tomography, magnetic resonance imaging, and positron-emission tomography in the diagnosis and characterization of pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic diseases, when used in conjunction with gastrointestinal endoscopy?", "What are the most effective imaging techniques for diagnosing pancreatic neoplasms, chronic pancreatitis, pancreatic cysts, and other pancreatic disorders? Specifically, I am interested in studies that focus on the use of elasticity imaging techniques such as elastography, sonoelastography, and acoustography, as well as ultrasonography, endosonography, and various forms of tomography including X-Ray, Positron-Emission, and Magnetic Resonance Imaging. The search should also include studies that utilize gastrointestinal endoscopy to aid in the diagnosis of these pancreatic disorders."]}
{"id": "CD011431", "boolean": "(Malaria[mesh] OR Plasmodium[mesh] OR Malaria[Title/Abstract]) AND (Reagent kits, diagnostic[mesh] OR immunoassay[mesh:noexp] OR chromatography[mesh:noexp] OR Enzyme-linked immunosorbent assay[mesh:noexp] OR rapid diagnos* test*[Title/Abstract] OR RDT[Title/Abstract] OR Dipstick*[Title/Abstract] OR Rapid diagnos* device*[Title/Abstract] OR MRDD[Title/Abstract] OR OptiMal[Title/Abstract] OR Binax NOW[Title/Abstract] OR ParaSight[Title/Abstract] OR Immunochromatograph*[Title/Abstract] OR Antigen detection method*[Title/Abstract] OR Rapid malaria antigen test*[Title/Abstract] OR Combo card test*[Title/Abstract] OR Rapid test*[Title/Abstract] OR Card test*[Title/Abstract] OR (Rapid[All Fields] AND (detection*[Title/Abstract] OR diagnos*[Title/Abstract]))", "generated_query": ["What is the effectiveness of reagent kits, immunoassays, chromatography, enzyme-linked immunosorbent assays, rapid diagnostic tests, dipsticks, rapid diagnostic devices, and other antigen detection methods in diagnosing malaria caused by Plasmodium or any other species of the disease?", "What is the effectiveness of reagent kits and diagnostic tools for detecting Malaria or Plasmodium, including immunoassay, chromatography, and Enzyme-linked immunosorbent assay, as well as rapid diagnos* tests, RDTs, Dipsticks, and MRDD or OptiMal or Binax NOW or ParaSight or Immunochromatography or Antigen detection methods or Rapid malaria antigen tests or Combo card tests or Rapid tests or Card tests or Rapid detection or diagnosis using a semantic-based search engine?", "What is the effectiveness of reagent kits, immunoassays, and other diagnostic tools for detecting Malaria or Plasmodium? Specifically, I am interested in Enzyme-linked immunosorbent assay, rapid diagnos* tests, dipsticks, rapid diagnos* devices, MRDD, OptiMal, Binax NOW, ParaSight, immunochromatography, antigen detection methods, combo card tests, and card tests, as well as any other methods that utilize rapid detection or diagnosis for Malaria or Plasmodium.", "What is the effectiveness of diagnostic methods for detecting Malaria or Plasmodium, including reagent kits, immunoassays, chromatography, enzyme-linked immunosorbent assays, rapid diagnostic tests, dipsticks, rapid diagnostic devices, OptiMal, Binax NOW, ParaSight, immunochromatography, antigen detection methods, and rapid malaria antigen tests?", "What are the most effective reagent kits and diagnostic methods for diagnosing malaria caused by Plasmodium, as assessed by immunoassay, chromatography, Enzyme-linked immunosorbent assay, rapid diagnostic tests, dipsticks, rapid diagnostic devices, MRDD, OptiMal, Binax NOW, ParaSight, Immunochromatography, antigen detection methods, combo card tests, or card tests?", "What is the diagnostic accuracy of reagent kits, immunoassays, chromatography, and rapid diagnostic tests, such as Rapid Diagnostic Tests, Dipsticks, and Rapid Diagnosis Devices, for detecting Malaria caused by Plasmodium or otherwise, as compared to Enzyme-linked immunosorbent assays, MRDD, OptiMal, Binax NOW, ParaSight, Immunochromatography, Antigen Detection Methods, Combo Card Tests, or Card Tests? Also, are there any studies that investigate the effectiveness of the Rapid Detection or Diagnosis in relation to Malaria detection or diagnosis?", "What is the diagnostic accuracy of reagent kits, immunoassays, chromatography, ELISA, and various rapid diagnostic tests (RDTs) for the detection of malaria caused by Plasmodium or the presence of malaria in general?", "What is the diagnostic accuracy of reagent kits, immunoassays, chromatography, enzyme-linked immunosorbent assays, and rapid diagnostic tests for malaria caused by Plasmodium or Malaria as determined by tests such as Dipstick, MRDD, OptiMal, Binax NOW, ParaSight, Immunochromatography, rapid malaria antigen tests, combo card tests, or rapid tests with a focus on rapid detection and diagnosis?", "What are the most effective reagent kits, diagnostic tools, and immunoassays for diagnosing malaria caused by Plasmodium, and what are the limitations of these diagnostic methods?", "What is the effectiveness of reagent kits, diagnostic tests and assays for detecting malaria caused by Plasmodium and other strains, including rapid diagnostic tests, immunoassays, enzyme-linked immunosorbent assays, and chromatography?"]}
{"id": "CD011515", "boolean": "(endoscop*[Title/Abstract] OR Endoscopy[mesh]) AND (\"Ampulla of Vater\"[mesh] OR ampulla vateri[Title/Abstract] OR ampullovateric[Title/Abstract] OR papilla vateri[Title/Abstract] OR vater papilla[Title/Abstract] OR vater ampulla[Title/Abstract] OR periampull*[Title/Abstract] OR peri-ampull*[Title/Abstract] OR choledoch*[Title/Abstract] OR alcholedoch*[Title/Abstract] OR bile duct*[Title/Abstract] OR biliary[Title/Abstract] OR cholangio*[Title/Abstract] OR gall duct[Title/Abstract] OR duoden*[Title/Abstract] OR small bowel[Title/Abstract] OR small intestin*[Title/Abstract] OR enter*[Title/Abstract] OR pancrea*[Title/Abstract]) AND (Positron-Emission Tomography[mesh:noexp] OR Magnetic Resonance Imaging[mesh] OR PET[Title/Abstract] OR MRI[Title/Abstract] OR NMRI[Title/Abstract] OR zeugmatogra*[Title/Abstract] OR ((emission[Title/Abstract] OR positron[Title/Abstract] OR magneti*[Title/Abstract] OR MR[Title/Abstract] OR NMR[Title/Abstract] OR proton[Title/Abstract] OR acoustic[Title/Abstract] OR ARFI[Title/Abstract]) AND (tomogra*[Title/Abstract] OR scan[Title/Abstract] OR scans[Title/Abstract] OR imaging[Title/Abstract]))) AND (pancreatectomy[mesh:noexp] OR pancreaticoduodenectomy[mesh:noexp] OR pancreaticojejunostomy[mesh:noexp] OR pancreatect*[Title/Abstract] OR pancreaticojejunost*[Title/Abstract] OR pancreaticogastros*[Title/Abstract] OR pancreaticoduodenect*[Title/Abstract] OR duodenopancreatectom*[Title/Abstract] OR pancreato-biliary[Title/Abstract]) AND (General Surgery[mesh:noexp] OR Surgical Procedures, Operative[mesh] OR surger*[Title/Abstract] OR surgical*[Title/Abstract] OR operat*[Title/Abstract] OR resection*[Title/Abstract] OR preoperative[Title/Abstract]) AND (Ultrasonography[mesh] OR echogra*[Title/Abstract] OR ultrason*[Title/Abstract] OR ultrasound[Title/Abstract])", "generated_query": ["What is the effectiveness of endoscopic imaging techniques in diagnosing and guiding surgical intervention for tumors and disorders of the Ampulla of Vater, including periampullary and biliary diseases, utilizing advanced imaging technologies such as positron-emission tomography, magnetic resonance imaging, and ultrasonography, in conjunction with pancreaticoduodenectomy and other operative procedures?", "What is the effectiveness of endoscopy, positron-emission tomography, magnetic resonance imaging, and ultrasonography in pancreaticobiliary surgeries such as pancreatoduodenectomy and pancreaticojejunostomy?", "What is the effectiveness of endoscopy or endoscop* combined with imaging modalities such as PET, MRI, or ultrasound for the diagnosis and surgical management of diseases involving the Ampulla of Vater, bile ducts, pancreas, and surrounding structures, specifically in the context of pancreaticoduodenectomy, pancreato-biliary surgeries, and resections?", "What is the diagnostic accuracy of endoscopy, PET, and MRI for the assessment of periampullary tumors in patients undergoing pancreatobiliary surgery?", "What is the effectiveness of endoscopy and various imaging techniques (including PET, MRI, and ultrasound) in pancreatic and periampullary cancer, particularly in the context of surgical intervention (such as pancreaticoduodenectomy or pancreato-biliary procedures)?", "What is the effectiveness of endoscopy or endoscopic procedures, combined with imaging techniques such as positron emission tomography (PET) or magnetic resonance imaging (MRI), in patients undergoing pancreatic or biliary surgery or resection, with a focus on the ampulla of Vater and surrounding structures, including the duodenum, small bowel, and pancreas, as assessed by ultrasonography or other imaging modalities?", "What are the most effective diagnostic imaging modalities and surgical techniques for the management of periampullary tumors, including those of the ampulla of Vater, bile duct, and pancreas, as assessed by endoscopic and ultrasonographic examinations, PET and MRI imaging, and surgical procedures, such as pancreatoduodenectomy, pancreaticojejunostomy, or pancreaticogastrostomy?", "What is the efficacy of endoscopy, positron-emission tomography, magnetic resonance imaging, and ultrasonography in the diagnosis and treatment of pancreatic and biliary diseases, specifically those related to the Ampulla of Vater, periampullary region, choledochus, and small intestine, and following surgical procedures such as pancreatectomy and pancreaticoduodenectomy?", "What is the efficacy of endoscopy or endoscopic procedures such as pancreato-biliary surgery, pancreaticoduodenectomy, and pancreaticojejunostomy, in conjunction with imaging techniques like ultrasonography, positron-emission tomography, and magnetic resonance imaging, for the diagnosis and treatment of conditions involving the Ampulla of Vater, periampullary area, bile duct, small intestine, and pancreas?", "What is the diagnostic accuracy of endoscopy (including endoscopic retrograde cholangiopancreatography) and imaging modalities (including positron emission tomography and magnetic resonance imaging) for the preoperative detection of ampullary neoplasms, specifically in patients undergoing pancreaticoduodenectomy or pancreato-biliary surgery?"]}
{"id": "CD011126", "boolean": "(uterine diseases[mesh] OR Ovarian Diseases[mesh] OR leiomyoma[mesh] OR endometriosis[mesh] OR Gynecology[mesh:noexp] OR Endometrial Hyperplasia[mesh:noexp] OR Adenomyoma[mesh:noexp] OR uterine hemorrhage[mesh] OR Polyps[mesh:noexp] OR myoma[mesh] OR Infertility[mesh:noexp] OR infertil*[Text Word] OR endometri*[Text Word] OR heavy menstrual bleeding[Text Word] OR arcuate uter*[Text Word] OR subfertil*[Text Word] OR Adenomyo*[Text Word] OR fibroma[Text Word] OR abnormal vagina*[Text Word] OR uter*[Text Word] OR DUB[Text Word] OR fibromyoma*[Text Word] OR polyp*[Text Word] OR myoma*[Text Word] OR intracav*[Text Word] OR intracavity abnormal*[Text Word] OR adenomyosis[Text Word] OR fibroid*[Text Word] OR intracav*[Text Word] OR uter*[Text Word] OR dysfunctional uter*[Text Word] OR metrorrhagi*[Text Word] OR abnormal uter*[Text Word] OR uter*[Text Word] OR adnexal mass*[Text Word] OR endometrial cavity[Text Word] OR menorrhagi*[Text Word] OR endometrio*[Text Word] OR leiomyoma*[Text Word] OR (endometri*[Text Word] AND patholog*[Text Word]) OR (ovar*[Text Word] AND cyst*[Text Word]) OR (postmenopaus*[Text Word] AND bleed*[Text Word]) OR (uterus[Text Word] AND disease*[Text Word]) OR (uterine[Text Word] AND neoplasm*[Text Word]) OR (ovar*[Text Word] AND mass*[Text Word]) OR (intrauter*[Text Word] AND patholog*[Text Word]) OR (endometri*[Text Word] AND anomal*[Text Word]) OR (uter*[Text Word] AND lesion*[Text Word]) OR (septate[Text Word] AND uterus[Text Word]) OR ((uter*[Text Word] AND malignan*[Text Word]) OR (uter*[Text Word] AND cancer*[Text Word])) OR ((endometri*[Text Word] AND malignan*[Text Word]) OR (endometri*[Text Word] AND cancer*[Text Word])) OR (ovar*[Text Word] AND volume*[Text Word]) OR (uter*[Text Word] AND contour[Text Word]) OR (uterine[Text Word] AND disease*[Text Word]) OR (uter*[Text Word] AND abnormal*[Text Word]) OR (uterine[Text Word] AND anomal*[Text Word]) OR (intrauter*[Text Word] AND lesion*[Text Word]) OR (endometri*[Text Word] AND tumour*[Text Word]) OR (uterine[Text Word] AND anomal*[Text Word]) OR (ovar*[Text Word] AND tumo*[Text Word]) OR (uter*[Text Word] AND volume[Text Word]) OR (endometri*[Text Word] AND adhesion*[Text Word]) OR (bicornuate[Text Word] AND uterus[Text Word]) OR (endometri*[Text Word] AND lesion*[Text Word]) OR (endometri*[Text Word] AND neoplasm*[Text Word]) OR (uterus[Text Word] AND patholog*[Text Word]) OR (uter*[Text Word] AND adhesion*[Text Word]) OR (ovar*[Text Word] AND adhesion*[Text Word]) OR (intrauter*[Text Word] AND adhesion*[Text Word]) OR (endometri*[Text Word] AND tumor*[Text Word]) OR (uterine[Text Word] AND disorder*[Text Word]) OR (gynecolog*[Text Word] OR gynaecolog*[Text Word]) OR (intrauterine[Text Word] AND anomal*[Text Word]) OR (perimenopaus*[Text Word] AND bleed*[Text Word]) OR (uterus[Text Word] AND disorder*[Text Word]) OR (uterus[Text Word] AND neoplasm*[Text Word]) OR (endometri*[Text Word] AND thick*[Text Word]) OR (uter*[Text Word] AND malformation*[Text Word]) OR ((ovar*[Text Word] AND malignan*[Text Word]) OR (ovar*[Text Word] AND cancer*[Text Word])) OR (intrauter*[Text Word] AND abnormal*[Text Word]) OR (uter*[Text Word] AND sept*[Text Word]) OR (endometri*[Text Word] AND abnormal*[Text Word]) OR (uterine[Text Word] AND patholog*[Text Word]) OR (Endometri*[Text Word] AND Hyperplasia[Text Word])) AND (Imaging, Three-Dimensional[mesh:noexp] OR 3D US[Text Word] OR 3dus[Text Word] OR three dimension[Text Word] OR (Three-Dimensional[Text Word] AND ultraso*[Text Word]) OR (3D[Text Word] AND ultraso*[Text Word]) OR (3 D[Text Word] AND ultraso*[Text Word]) OR ((3D[Text Word] AND imag*[Text Word])) OR (3d[Text Word] AND multiplanar[Text Word]) OR (three dimensional[Title/Abstract] OR 3d[Title/Abstract] OR 3 d[Title/Abstract]) OR ((3D[Text Word] AND imag*[Text Word])) OR (Three-Dimensional[Text Word] AND sonogra*[Text Word]) OR (3D[Text Word] AND sonogra*[Text Word]) OR (3 D[Text Word] AND sonogra*[Text Word]) OR (3 dimension*[Text Word] AND multiplanar[Text Word]) OR (three dimension*[Text Word] AND multiplanar[Text Word]) OR (Three-Dimensional[Text Word] AND imag*[Text Word]) OR (3 D[Text Word] AND imag*[Text Word]) OR (3D[Text Word] AND imag*[Text Word]))", "generated_query": ["What is the effectiveness of 3D ultrasound imaging in diagnosing uterine and ovarian diseases such as leiomyoma, endometriosis, polyps, myoma, infertility, abnormal vaginal bleeding, adenomyosis, and fibroids?", "What is the effectiveness of Three-Dimensional imaging and ultrasound techniques in diagnosing and managing uterine and ovarian diseases such as leiomyoma, endometriosis, endometrial hyperplasia, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, and abnormal vaginal bleeding?", "What is the effectiveness of 3D ultrasound imaging in the diagnosis and management of various uterine and ovarian conditions, such as uterine diseases, ovarian diseases, leiomyoma, endometriosis, Gynecology, Endometrial Hyperplasia, Adenomyoma, uterine hemorrhage, Polyps, myoma, Infertility, infertil*, heavy menstrual bleeding, arcuate uter*, subfertil*, Adenomyo*, fibroma, abnormal vagina*, DUB, fibromyoma*, polyp*, myoma*, intracav*, intracavity abnormal*, adenomyosis, fibroid*, dysfunctional uter*, metrorrhagi*, abnormal uter*, adnexal mass*, endometrial cavity, menorrhagi*, endometrio*, leiomyoma*, and other related conditions?", "What is the effectiveness of using three-dimensional imaging or 3D ultrasound in the diagnosis and management of uterine diseases, ovarian diseases, leiomyoma, endometriosis, Gynecology, endometrial hyperplasia, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, heavy menstrual bleeding, arcuate uterus, subfertility, adenomyosis, fibroma, abnormal vaginal bleeding, dysfunctional uterus, metrorrhagia, adnexal masses, endometrial cavity, menorrhagia, leiomyoma, and other related pathologies?", "What is the efficacy of 3D ultrasound in the diagnosis and management of various uterine and ovarian diseases, such as leiomyoma, endometriosis, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, and abnormal vaginal bleeding?", "What is the effectiveness of Three-Dimensional imaging, including 3D US, multiplanar, and sonography, in the diagnosis and management of uterine and ovarian diseases such as leiomyoma, endometriosis, endometrial hyperplasia, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, abnormal vaginal bleeding, arcuate uterine anomalies, subfertility, fibroma, DUB, intracavity abnormalities, adenomyosis, fibroids, dysfunctional uterus, metrorrhagia, adnexal masses, endometrial cavity, menorrhagia, and uterine and ovarian neoplasms?", "What is the effectiveness of using Three-Dimensional imaging, including 3D US, multiplanar imaging, and sonography, for the diagnosis of various uterine and ovarian diseases such as leiomyoma, endometriosis, uterine hemorrhage, polyps, myoma, infertility, and abnormal uterine bleeding?", "What is the effectiveness of 3D ultrasound imaging in diagnosing and managing uterine and ovarian diseases, including leiomyoma, endometriosis, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, and abnormal vaginal bleeding, among others?", "What is the effectiveness of Three-Dimensional Imaging in the diagnosis of uterine and ovarian diseases such as leiomyoma, endometriosis, Gynecology, Adenomyoma, uterine hemorrhage, Polyps, myoma, Infertility, and other related conditions?", "What is the effectiveness of Three-Dimensional Imaging, 3D US, and multiplanar imaging in diagnosing and evaluating uterine diseases, ovarian diseases, leiomyoma, endometriosis, Gynecology, endometrial hyperplasia, adenomyoma, uterine hemorrhage, polyps, myoma, infertility, infertile conditions, heavy menstrual bleeding, arcuate uterus, subfertility, fibroma, abnormal vaginal conditions, dysfunctional uterine bleeding, metrorrhagia, adnexal masses, endometrial cavity, menorrhagia, endometriosis, ovarian cysts, postmenopausal bleeding, uterus diseases, uterine neoplasms, intrauterine pathologies, endometrial anomalies, uterine lesions, septate uterus, uterine malignancies, ovarian masses, uterine volumes, endometrial adhesions, bicornuate uterus, endometrial lesions, endometrial neoplasms, and gynecological disorders?"]}
{"id": "CD009694", "boolean": "((brain dea* OR brain stem dea* OR coma depasse OR irreversible coma) AND (CT OR CTA OR CTCA OR comput* tomograph* OR comput* aided)) OR ((tomograph* OR comput* tomograph* angio* OR comput* aided tomograph* angio*) AND humans)", "generated_query": ["What is the effectiveness of using CT or CTA or CTCA or computer tomography or computer-aided techniques in the diagnosis of brain death or irreversible coma, including brain stem death, or in the identification of individuals in a coma depasse state? Additionally, are there any studies that have specifically investigated the use of tomography or computer-aided techniques in humans in these contexts?", "What is the efficacy of CT, CTA, CTCA, or computer-aided tomography in diagnosing brain death, brain stem death, irreversible coma, or coma depasse? Additionally, what are the relevant studies involving humans and the use of tomography or computer-aided tomography angiography in relation to these conditions?", "What is the efficacy of CT or CTA or CTCA or computer-aided tomography in detecting brain death or irreversible coma, and how does it compare to tomography or computer-aided tomography angiography in humans?", "What is the effectiveness of using CT or computationally aided imaging techniques to diagnose brain death, brain stem death, coma depasse, or irreversible coma in human patients, or to conduct angiography of the brain using such techniques?", "What is the effectiveness of using CT, CTA, CTCA, or computer-aided tomography in diagnosing brain death, brain stem death, coma depasse, or irreversible coma in humans? Additionally, are there any studies that investigate the use of tomography or computer-aided tomography angiography in diagnosing these conditions?", "What is the effectiveness of CT or computer-aided tomography in diagnosing brain death, brain stem death, coma depasse, and irreversible coma in humans?", "What are the most effective diagnostic imaging techniques for identifying brain death, brain stem death, coma depasse, or irreversible coma in humans, and how have computer-aided methods improved their accuracy?", "What are the latest findings on the use of brain death, brain stem death, coma depasse, and irreversible coma in conjunction with CT, CTA, CTCA, or computer-aided tomography in humans? Also, what is the effectiveness of tomography, computer-aided tomography, or angio tomography in diagnosing these conditions in humans?", "What is the effectiveness of CT or computationally aided imaging techniques in diagnosing brain death or irreversible coma in humans, including brain stem death, coma depasse, or related conditions?", "What is the effectiveness of using brain dea*, brain stem dea*, coma depasse, or irreversible coma with CT, CTA, CTCA, comput* tomograph*, or comput* aided, as well as tomograph*, comput* tomograph* angio*, or comput* aided tomograph* angio*, in humans for the diagnosis of neurological conditions?"]}
{"id": "CD008587", "boolean": "(Uterine Cervical Neoplasms[mesh] OR Uterine Cervical Dysplasia[mesh] OR Cervical Intraepithelial Neoplasia[mesh] OR ((cervix[Text Word] OR cervical[Text Word] OR cervico*[Text Word]) AND (cancer*[Text Word] OR carcinoma[All Fields] OR adenocarcinoma[All Fields] OR neoplas*[Text Word] OR dysplas*[Text Word] OR dyskaryos*[Text Word] OR squamous[Text Word] OR CIN[Text Word] OR CINII*[Text Word] OR CIN2*[Text Word] OR CINIII*[Text Word] OR CIN3*[Text Word] OR SIL[Text Word] OR HSIL[Text Word] OR H-SIL[Text Word] OR LSIL[Text Word] OR L-SIL[Text Word] OR ASCUS[Text Word] OR AS-CUS[Text Word]))) AND (Vaginal smears[mesh] OR Cytodiagnosis[mesh] OR Cell Transformation, Viral[mesh] OR Cytopathogenic Effect, Viral[mesh] OR ((pap[Text Word] OR papanicolaou[Text Word] OR vagina*[Text Word] OR cervical[Text Word] OR cervix[Text Word] OR cervico*[Text Word] OR cytolog*[Text Word]) AND (smear*[All Fields] OR test[Text Word] OR tests[Text Word] OR testing[Text Word] OR tested[Text Word] OR swab*[All Fields] OR scrap*[All Fields]))) AND (papillomaviridae[mesh:noexp] OR alphapapillomavirus[mesh] OR \"DNA, viral\"[mesh] OR Papillomavirus Infections[mesh] OR Tumor Virus Infections[mesh] OR \"cervix uteri\"[mesh] OR HPV[Text Word] OR \"human papillomavirus\"[Text Word] OR papillomaviridae[Text Word] OR PCR[All Fields] OR \"hybrid capture*\"[Text Word] OR HC2[Text Word] OR HCII[Text Word] OR \"HC 2\"[Text Word] OR \"HC II\"[Text Word])", "generated_query": ["Can you find relevant studies on the association between cervical neoplasms/dysplasia/CIN and vaginal smears/cytodiagnosis/papillomaviridae/HPV using a comprehensive search strategy that includes related keywords such as cervix, cancer, dysplasia, and papillomavirus?", "Please retrieve all studies that investigate the correlation between Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, Cervical Intraepithelial Neoplasia, and related conditions with Vaginal smears, Cytodiagnosis, and Cell Transformation, Viral, as well as Papillomaviridae, alphapapillomavirus, \"DNA, viral\", Papillomavirus Infections, Tumor Virus Infections, \"cervix uteri\", HPV, \"human papillomavirus\", PCR, \"hybrid capture*\", HC2, HCII, \"HC 2\", and \"HC II\". The search should also include studies that use keywords such as cervix, cervical, cervico, cancer, carcinoma, adenocarcinoma, neoplasia, dysplasia, dyskaryos, squamous, CIN, CINII, CIN2, CINIII, CIN3, SIL, HSIL, H-SIL, LSIL, L-SIL, ASCUS, AS-CUS, smear, test, tests, testing, tested, swab, and scrap.", "What is the efficacy of various diagnostic tests for detecting uterine cervical neoplasms, dysplasia, and intraepithelial neoplasia, as well as the role of papillomaviruses and HPV in the development of these conditions, as measured by studies that use vaginal smears, cytodiagnosis, pap testing, and molecular methods such as PCR and hybrid capture?", "What is the effectiveness of tests for detecting Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, or Cervical Intraepithelial Neoplasia using Vaginal smears, Cytodiagnosis, Cell Transformation, Viral, or Papillomavirus Infections, and what is the role of papillomaviridae, alphapapillomavirus, DNA viral, HPV, PCR, and hybrid capture in their detection?", "What is the association between cervical neoplasms/dysplasia and cytodiagnosis/vaginal smears, cell transformation by papillomaviridae, and human papillomavirus (HPV)?", "Can vaginal smears, cytodiagnosis, and cell transformation/viral cytopathogenic effects detect or diagnose uterine cervical neoplasms, dysplasia, or intraepithelial neoplasia, as well as HPV or papillomavirus infections, using tests such as Pap, HPV DNA testing, PCR, or hybrid capture?", "Retrieve studies on uterine cervical neoplasms and dysplasia, cervical intraepithelial neoplasia, and related terms including cancer, carcinoma, adenocarcinoma, neoplasia, dysplasia, squamous, CIN, SIL, HSIL, LSIL, ASCUS, and papillomaviridae, alpha papillomavirus, DNA viral, HPV, and PCR. The search should also include studies on vaginal smears, cytodiagnosis, and cell transformation, viral, using terms such as pap, papanicolaou, vagina, cervix, cytology, smear, test, and swab. The search should be conducted using the boolean operators AND and OR to ensure relevant studies are retrieved.", "Can screening techniques like vaginal smears or cytodiagnosis detect uterine cervical neoplasms, dysplasia or intraepithelial neoplasia caused by papillomaviridae, alphapapillomavirus or human papillomavirus?", "What is the association between uterine cervical neoplasms, cervical intraepithelial neoplasia, cervical dysplasia, and various forms of cervical cancer (including adenocarcinoma and squamous cell carcinoma) with the detection of abnormal cells via vaginal smears or cytodiagnosis, and their relationship with papillomaviridae, alphapapillomavirus, and HPV infections, as determined by PCR or hybrid capture assays such as HC2 or HCII?", "Retrieve articles related to cervical cancer and its precursors, including cervical intraepithelial neoplasia and dysplasia, as well as screening methods such as pap smears and HPV testing. Search for articles on the human papillomavirus, papillomaviridae, and alpha papillomavirus, using search terms such as cervix, cervical, carcinoma, neoplasia, dysplasia, papillomavirus, PCR, and hybrid capture. Include articles on the cytopathologic effects of HPV and other viral infections, as well as articles on the effectiveness of different screening methods in detecting and preventing cervical cancer."]}
{"id": "CD008892", "boolean": "(typhoid fever[mesh:noexp] OR Salmonella enterica[mesh] OR paratyphoid fever[mesh] OR \"typhoid fever\"[All Fields] OR \"paratyphoid fever\"[All Fields] OR \"enteric fever\"[All Fields] OR typhi[Title/Abstract] OR paratyphi[Title/Abstract] OR \"salmonella enterica\"[Title/Abstract]) AND (serodiagnosis[mesh:noexp] OR immunoblotting[mesh:noexp] OR Reagent Kits, Diagnostic[mesh:noexp] OR Serologic Tests[mesh:noexp] OR \"immunochromatographic lateral flow assay*\"[Title/Abstract] OR \"serodiagnostic test*\"[Title/Abstract] OR \"rapid diagnostic test*\"[Title/Abstract] OR RDT*[Title/Abstract] OR (typhirapid[Title/Abstract] OR \"latex agglutination\"[Title/Abstract] OR \"test-it-typhoid\"[Title/Abstract] OR enterocheck[Title/Abstract] OR \"SD bioline\"[Title/Abstract] OR \"dip-s-tick\"[Title/Abstract] OR panbio[Title/Abstract] OR \"mega salmonella\"[Title/Abstract] OR naats[Title/Abstract] OR \"nucleid acid amplication test*\"[Title/Abstract]) OR (\"blood culture*\"[Title/Abstract] OR \"bone marrow culture*\"[Title/Abstract]) OR (Widal[Title/Abstract] OR \"DOT enzyme immunoassay\"[Title/Abstract] OR typhiDOT[Title/Abstract] OR TUBEX[Title/Abstract]) OR (\"solid-phase\"[Title/Abstract] OR \"DOT blot\"[Title/Abstract]) OR (\"antigen detection\"[Title/Abstract] OR \"antibody detection\"[Title/Abstract]))", "generated_query": ["What are the best diagnostic tests for detecting typhoid fever and paratyphoid fever, including serodiagnostic tests, rapid diagnostic tests, blood cultures, bone marrow cultures, Widal, DOT enzyme immunoassay, TUBEX, solid-phase, DOT blot, antigen detection, and antibody detection?", "What are the most effective serodiagnostic and culture-based tests for diagnosing typhoid fever caused by Salmonella enterica or paratyphoid fever? Include tests such as immunoblotting, rapid diagnostic tests, blood and bone marrow cultures, Widal test, and antigen/antibody detection.", "What is the diagnostic accuracy of serological tests, rapid diagnostic tests, nucleic acid amplification tests, blood/bone marrow cultures, Widal test, DOT enzyme immunoassay, TUBEX, solid-phase, DOT blot, antigen detection, and antibody detection for the diagnosis of typhoid fever, Salmonella enterica, and paratyphoid fever?", "What are the most accurate diagnostic tests for typhoid and paratyphoid fever, including serological and antigen detection methods, blood and bone marrow cultures, and nucleic acid amplification tests such as typhirapid, latex agglutination, test-it-typhoid, enterocheck, SD bioline, dip-s-tick, panbio, mega salmonella, and naats?", "What are the most effective diagnostic tests for typhoid fever, Salmonella enterica, and paratyphoid fever, including serodiagnostic tests, rapid diagnostic tests, blood culture, bone marrow culture, Widal test, and antigen/antibody detection, as well as immunochromatographic lateral flow assays, latex agglutination, nucleic acid amplification tests, and DOT enzyme immunoassay?", "What are the most effective diagnostic tests for detecting typhoid fever, Salmonella enterica, or paratyphoid fever? Specifically, I am looking for information on serodiagnostic tests such as immunoblotting, Reagent Kits, Diagnostic, Serologic Tests, immunochromatographic lateral flow assay, and rapid diagnostic tests. Additionally, I am interested in traditional diagnostic methods such as blood culture and bone marrow culture, as well as newer techniques like nucleid acid amplication tests and antigen or antibody detection methods. The query should also include relevant keywords like Widal, DOT enzyme immunoassay, TUBEX, solid-phase, and DOT blot.", "What are the most effective serodiagnostic tests and culture methods for detecting typhoid fever, paratyphoid fever, and Salmonella enterica, including the use of immunoblotting, Reagent Kits, Diagnostic, and Serologic Tests, as well as the novel techniques of immunochromatographic lateral flow assays, latex agglutination, nucleic acid amplification tests, DOT enzyme immunoassays, TUBEX, solid-phase and DOT blot techniques, and antigen and antibody detection?", "What is the effectiveness of serodiagnosis, immunoblotting, and various diagnostic tests in the detection of typhoid fever, Salmonella enterica, and paratyphoid fever?", "What is the diagnostic accuracy of various serodiagnostic tests and culture methods for detecting typhoid fever, Salmonella enterica, and paratyphoid fever? Specifically, I am interested in studies that evaluate immunoblotting, rapid diagnostic tests (such as immunochromatographic lateral flow assays), latex agglutination, blood culture, bone marrow culture, DOT enzyme immunoassay, solid-phase assays, DOT blot assays, and antigen or antibody detection methods. Relevant studies should include the following terms: typhoid fever, Salmonella enterica, paratyphoid fever, enteric fever, typhi, paratyphi, serodiagnosis, Reagent Kits, Diagnostic, Serologic Tests, Widal, and nucleic acid amplification tests.", "What are the most effective methods for serodiagnosis of typhoid fever, Salmonella enterica, and paratyphoid fever, including immunoblotting, diagnostic reagent kits, serologic tests, immunochromatographic lateral flow assays, rapid diagnostic tests, blood and bone marrow cultures, Widal tests, DOT enzyme immunoassays, solid-phase assays, DOT blots, antigen detection, and antibody detection?"]}
{"id": "CD012179", "boolean": "(Luteinizing Hormone[mesh] OR Progesterone[mesh] OR matrix metalloproteinase 1[mesh] OR matrix metalloproteinase 2[mesh] OR matrix metalloproteinase 3[mesh] OR matrix metalloproteinase 9[mesh] OR \"tissue inhibitor of metalloproteinase-1\"[mesh] OR \"tissue inhibitor of metalloproteinase-2\"[mesh] OR Glycoproteins[mesh] OR Follistatin[mesh] OR intercellular adhesion molecule-1[mesh] OR selectins[mesh] OR t-lymphocytes[mesh] OR natural killer t-cells[mesh] OR hla antigens[mesh] OR hla-a1 antigen[mesh] OR hla-a2 antigen[mesh] OR Integrins[mesh] OR Cysteine-Rich Protein 61[mesh] OR Vascular Endothelial Growth Factor A[mesh:noexp] OR Vitamin D-Binding Protein[mesh:noexp] OR Cytokines[mesh] OR interleukins[mesh] OR interleukin-1[mesh] OR interleukin-6[mesh] OR interleukin-8[mesh] OR interleukin-12[mesh] OR interleukin-13[mesh] OR Epidermal Growth Factor[mesh] OR Fibroblast Growth Factors[mesh] OR Platelet-Derived Growth Factor[mesh:noexp] OR Keratin-19[mesh:noexp] OR Clinical Laboratory Techniques[mesh] OR Endometriosis[mesh:noexp] OR Laboratory Test*[Text Word] OR urinary VDBP corrected for creatinine expression[Text Word] OR MMP*[Text Word] OR proteomic*[Text Word] OR cytokeratin-19[Text Word] OR Total complement level*[Text Word] OR Autoantibodies[Text Word] OR estrogen receptor*[Text Word] OR Anti-thyroid[Text Word] OR Anti-LDL[Text Word] OR MTMMP*[Text Word] OR urinary peptide*[Text Word] OR cyr61[Text Word] OR microRNA*[Text Word] OR cytokine*[Text Word] OR serum marker*[Text Word] OR Integrin*[Text Word] OR Anti-endometrial[Text Word] OR inflammatory marker*[Text Word] OR progesterone receptor*[Text Word] OR serum placental protein*[Text Word] OR sICAM[Text Word] OR Immune cells alteration*[Text Word] OR interleukin*[Text Word] OR Selectin*[Text Word] OR genomic*[Text Word] OR urinary marker*[Text Word] OR Osteopontin*[Text Word] OR Proteolytic enzyme*[Text Word] OR soluble intercellular adhesion[Text Word] OR cell adhesion molecule*[Text Word] OR sVCAM*[Text Word] OR matrix metalloproteinase*[Text Word] OR TIMP*[Text Word] OR Anti-laminin-1[Text Word] OR Follistatin*[Text Word] OR Aromatase P450[Text Word] OR growth factor*[Text Word] OR hepatocyte growth factor[Text Word] OR Endometrial marker*[Text Word] OR CAMs[Text Word] OR Anti-Thomsen Friedenreich antigen*[Text Word] OR microarray*[Text Word] OR VDBP-Cr[Text Word] OR scatter factor*[Text Word] OR Soluble adhesion molecule*[Text Word] OR Anti-transferrin[Text Word] OR Fas ligand*[Text Word] OR cell surface marker*[Text Word] OR leptin*[Text Word] OR Antiphospholipid*[Text Word] OR Cadherin*[Text Word] OR cysteine-rich heparin-binding protein*[Text Word] OR neural marker*[Text Word] OR (EGF[Text Word] OR epidermal growth factor*[Text Word]) OR (MCP-I[Text Word] OR monocyte chemoattractant protein-I[Text Word]) OR (Annexin 1[Text Word] OR Annexin1[Text Word]) OR (FGF[Text Word] OR fibroblast growth factor*[Text Word]) OR (HLA[Text Word] OR human leucocyte antigen*[Text Word]) OR (endometri*[Text Word] AND biops*[Text Word]) OR (EGFR[Text Word] OR epidermal growth factor receptor*[Text Word]) OR (VEGF[Text Word] OR vascular endothelial growth factor*[Text Word]) OR (Ca-19-9[Text Word] OR Ca19-9[Text Word] OR cancer antigen 19-9[Text Word]) OR (ANXA 1[Text Word] OR ANXA1[Text Word]) OR (Luteinizing Hormone*[Text Word] OR LH[Text Word]) OR (Ca-125[Text Word] OR Ca125[Text Word] OR cancer antigen 125[Text Word]) OR (biomarker*[Text Word] OR marker*[Text Word]) OR (PDGF[Text Word] OR platelet derived growth factor*[Text Word]) OR (MIF[Text Word] OR migration inhibitory factor*[Text Word]) OR (VDBP[Text Word] OR vitamin D-binding protein*[Text Word]) OR (sEselectin[Text Word] OR soluble E-selectin[Text Word]) OR (Anti-2HSG[Text Word] OR Heremans-Schmidt glycoprotein[Text Word]) OR (TGF-b[Text Word] OR transforming growth factor beta[Text Word] OR TGFb[Text Word]) OR (TNF-a[Text Word] OR tumour necrosis factor*[Text Word]) OR (IGF-I[Text Word] OR insulin-like growth factor*[Text Word] OR IGF1[Text Word]) OR (T helper*[Text Word] OR T supressor*[Text Word] OR T helper*[Text Word]) OR (TGF-a[Text Word] OR transforming growth factor alfa[Text Word] OR TGFa[Text Word]) OR (PP 14[Text Word] OR PP14[Text Word]) OR (sEcadherin[Text Word] OR soluble E-cadherin[Text Word]) OR (PGP 9*[Text Word] OR PGP9*[Text Word] OR protein gene product*[Text Word])) AND (Endometriosis[mesh] OR Endometrio*[Text Word])", "generated_query": ["What are the biomarkers and molecular markers associated with endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, selectins, T-lymphocytes, HLA antigens, integrins, cytokines, interleukins, growth factors, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, Clinical Laboratory Techniques, and urinary markers, and how do they relate to immune cells alteration, inflammatory markers, estrogen receptors, and other endometrial markers?", "What are the potential biomarkers for the diagnosis and prognosis of endometriosis? Specifically, which of the following have been identified as potential biomarkers: luteinizing hormone, progesterone, matrix metalloproteinase 1, matrix metalloproteinase 2, matrix metalloproteinase 3, matrix metalloproteinase 9, tissue inhibitor of metalloproteinase-1, tissue inhibitor of metalloproteinase-2, glycoproteins, follistatin, intercellular adhesion molecule-1, selectins, t-lymphocytes, natural killer t-cells, hla antigens, hla-a1 antigen, hla-a2 antigen, integrins, cysteine-rich protein 61, vascular endothelial growth factor A, vitamin D-binding protein, cytokines, interleukins, interleukin-1, interleukin-6, interleukin-8, interleukin-12, interleukin-13, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, urinary VDBP corrected for creatinine expression, MMP, proteomics, cytokeratin-19, total complement level, auto", "What biomarkers and markers can be used for the diagnosis and management of endometriosis, and what is their effectiveness in detecting and monitoring the disease?", "\"Identify studies on the relationship between endometriosis and biomarkers such as luteinizing hormone, progesterone, matrix metalloproteinases, glycoproteins, integrins, cytokines, growth factors, and immune cells alteration. Also, include studies that have investigated the use of clinical laboratory techniques, proteomic analysis, urinary markers, and serum markers for the diagnosis and management of endometriosis.\"", "What biomarkers and markers are associated with endometriosis, and how do they relate to the pathophysiology of the disease? Specifically, I am interested in exploring the role of luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, integrins, vascular endothelial growth factor, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, cytokeratin-19, clinical laboratory techniques, urinary VDBP corrected for creatinine expression, proteomics, autoantibodies, estrogen receptors, anti-thyroid antibodies, anti-LDL antibodies, MMPs, urinary peptides, CYR61, microRNAs, soluble intercellular adhesion molecules, sICAM, and the immune cells alteration, as well as exploring the potential of these biomarkers as diagnostic and prognostic tools.", "What are the biomarkers associated with endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, cytokines, interleukins, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, and various laboratory and urinary markers, as well as genomic and proteomic markers, autoimmune markers, estrogen and progesterone receptors, and inflammatory markers?", "What are the markers and proteins associated with endometriosis? Specifically, I am interested in luteinizing hormone, progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, glycoproteins, follistatin, intercellular adhesion molecules, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, integrins, cytokines, interleukins, epidermal growth factor, fibroblast growth factors, platelet-derived growth factor, keratin-19, clinical laboratory techniques, urinary VDBP corrected for creatinine expression, proteomics, total complement level, autoantibodies, estrogen receptors, anti-thyroid, anti-LDL, urinary peptide, cyr61, microRNAs, serum markers, sICAM, immune cell alterations, genomic markers, osteopontin, proteolytic enzymes, soluble intercellular adhesion, cell adhesion molecules, sVCAM, anti-laminin-1, aromatase P450, growth factors, hepatocyte growth factor, endometrial markers, CAMs, anti-Thomsen Friedenreich antigen, microarrays, VDBP-Cr, scatter factor, soluble adhesion molecules,", "What is the association between endometriosis and various biomarkers, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, Glycoproteins, interleukins, growth factors, and urinary markers?", "What are the biomarkers, growth factors, cytokines, and other markers associated with endometriosis, including Luteinizing Hormone, Progesterone, matrix metalloproteinases, tissue inhibitors of metalloproteinases, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, HLA antigens, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, Clinical Laboratory Techniques, urinary VDBP corrected for creatinine expression, MMPs, cytokeratin-19, Total complement level, Autoantibodies, estrogen receptors, Anti-thyroid antibodies, Anti-LDL antibodies, MTMMPs, urinary peptides, cyr61, microRNAs, inflammatory markers, progesterone receptors, serum placental proteins, sICAM, immune cell alterations, interleukins, Selectins, genomic markers, urinary markers, Osteopontin, Proteolytic enzymes, soluble intercellular adhesion molecules, cell adhesion molecules, s", "\"Retrieve all studies investigating the association between endometriosis and the following biomarkers: Luteinizing Hormone, Progesterone, matrix metalloproteinase 1, matrix metalloproteinase 2, matrix metalloproteinase 3, matrix metalloproteinase 9, tissue inhibitor of metalloproteinase-1, tissue inhibitor of metalloproteinase-2, Glycoproteins, Follistatin, intercellular adhesion molecule-1, selectins, T-lymphocytes, natural killer T-cells, HLA antigens, HLA-A1 antigen, HLA-A2 antigen, Integrins, Cysteine-Rich Protein 61, Vascular Endothelial Growth Factor A, Vitamin D-Binding Protein, Cytokines, interleukins, interleukin-1, interleukin-6, interleukin-8, interleukin-12, interleukin-13, Epidermal Growth Factor, Fibroblast Growth Factors, Platelet-Derived Growth Factor, Keratin-19, Clinical Laboratory Techniques, Laboratory Tests, urinary VDBP corrected for creatinine expression, MMPs, proteomics, cytokeratin-19, Total complement"]}
{"id": "CD011926", "boolean": "((((((((((( \"Sepsis/blood\"[Mesh] OR \"Sepsis/cerebrospinal fluid\"[Mesh] OR \"Sepsis/diagnosis\"[Mesh] ))) OR neonatal sepsis) OR neonatal bacteremia) OR neonatal infections)) AND \"Infant, Newborn\"[Mesh])) AND ((((((((((polymerase chain reaction) OR pcr) OR real time pcr) OR multiplex pcr) OR molecular probes) OR nucleic acid amplification) OR hybridization) OR sequencing) OR pyrosequencing) OR genechip))) AND (((((diagnosis) OR detection) OR identification) OR rapid identification) OR diagnostic tool) AND 1940/01/01:2016/01/19[crdt] ", "generated_query": ["What are the most effective diagnostic tools for identifying sepsis in newborn infants, including neonatal sepsis, bacteremia, and other infections, using methods such as polymerase chain reaction (PCR), real-time PCR, multiplex PCR, molecular probes, nucleic acid amplification, hybridization, sequencing, and gene chip, as well as other rapid identification and detection techniques, from the earliest available literature up to January 19, 2016?", "What diagnostic tools have been effective in identifying neonatal sepsis in newborn infants from 1940 to 2016?", "What diagnostic tools and techniques are effective in identifying and detecting neonatal sepsis or bacteremia in newborn infants, using molecular biology methods such as PCR, real-time PCR, hybridization, sequencing, or genechip, from January 1940 to January 2016?", "\"Retrieve all systematic review articles related to the diagnosis of sepsis in newborn infants from 1940 to 2016 that focus on molecular detection techniques such as polymerase chain reaction, real-time PCR, nucleic acid amplification, hybridization, sequencing, pyrosequencing, or genechip and include keywords such as diagnosis, detection, identification, rapid identification, or diagnostic tool.\"", "What diagnostic tools and techniques have been effective in identifying neonatal sepsis and related infections in newborn infants between January 1, 1940 and January 19, 2016? Specifically, I am interested in articles that discuss the use of PCR, real time PCR, multiplex PCR, molecular probes, nucleic acid amplification, hybridization, sequencing, or genechip technologies for rapid identification, detection, and diagnosis of sepsis and related infections in newborn infants.", "What is the diagnostic effectiveness of polymerase chain reaction, genechip, and related methods in identifying sepsis, including neonatal sepsis and infections, in newborns from 1940 to 2016?", "\"Retrieve articles from January 1st, 1940 to January 19th, 2016 on the diagnosis, detection, identification, and rapid identification of neonatal sepsis, neonatal bacteremia, and neonatal infections using techniques such as polymerase chain reaction, real-time PCR, multiplex PCR, molecular probes, nucleic acid amplification, hybridization, sequencing, and genechip in newborn infants.\"", "What diagnostic tools are effective for identifying neonatal sepsis in newborn infants using polymerase chain reaction, real time pcr, multiplex pcr, molecular probes, nucleic acid amplification, hybridization, sequencing, pyrosequencing, or genechip techniques? The search should be limited to articles published between January 1, 1940, and January 19, 2016, and should include documents discussing the diagnosis, detection, identification, or rapid identification of neonatal sepsis or related infections in newborn infants. Relevant articles should also include Mesh terms related to sepsis, such as \"Sepsis/blood,\" \"Sepsis/cerebrospinal fluid,\" or \"Sepsis/diagnosis,\" as well as neonatal sepsis, neonatal bacteremia, or neonatal infections.", "What is the diagnostic effectiveness of polymerase chain reaction, molecular probes, nucleic acid amplification, hybridization, sequencing, pyrosequencing, and genechip for the rapid identification, detection, and diagnosis of neonatal sepsis, neonatal bacteremia, and neonatal infections in newborn infants from 1940 to 2016?", "What is the effectiveness of diagnostic tools for identifying neonatal sepsis in newborn infants, and what are the advantages and disadvantages of using polymerase chain reaction (PCR), real-time PCR, multiplex PCR, molecular probes, nucleic acid amplification, hybridization, sequencing, pyrosequencing, or genechip-based methods for diagnosis or rapid identification, as demonstrated in studies published from 1940/01/01 to 2016/01/19?"]}
{"id": "CD012009", "boolean": "(\"Ampulla of Vater\"[mesh] OR Pancreas[mesh] OR Bile Ducts[mesh] OR Duodenum[mesh] OR ampulla vateri[Title/Abstract] OR ampullovateric[Title/Abstract] OR papilla vateri[Title/Abstract] OR vater papilla[Title/Abstract] OR vater ampulla[Title/Abstract] OR periampull*[Title/Abstract] OR peri-ampull*[Title/Abstract] OR choledoch*[Title/Abstract] OR alcholedoch*[Title/Abstract] OR bile duct*[Title/Abstract] OR biliary[Title/Abstract] OR cholangio*[Title/Abstract] OR gall duct[Title/Abstract] OR duoden*[Title/Abstract] OR small bowel[Title/Abstract] OR small intestin*[Title/Abstract] OR enter*[Title/Abstract] OR pancrea*[Title/Abstract]) AND (Drainage[mesh] OR Anastomotic Leak[mesh] OR Pancreatic Fistula[mesh] OR drain*[Title/Abstract] OR leak[Title/Abstract] OR fistula[Title/Abstract]) AND (Amylases[mesh] OR amylase[Title/Abstract] OR amylases[Title/Abstract]) AND (Pancreatectomy[mesh] OR Pancreaticojejunostomy[mesh] OR Pancreaticoduodenectomy[mesh] OR pancreatect*[Title/Abstract] OR pancreaticojejunost*[Title/Abstract] OR pancreaticogastros*[Title/Abstract] OR pancreaticoduodenect*[Title/Abstract] OR duodenopancreatectom*[Title/Abstract])", "generated_query": ["What is the effectiveness of drainage and anastomotic leak prevention strategies following pancreatectomy or pancreaticoduodenectomy in relation to amylase levels and surgical techniques involving the Ampulla of Vater, Pancreas, Bile Ducts, and Duodenum?", "What is the effectiveness of pancreatic drainage procedures following pancreaticoduodenectomy or pancreatectomy, and what are the rates of anastomotic leaks and pancreatic fistulas? Specifically, I am interested in articles related to the Ampulla of Vater, pancreas, bile ducts, duodenum, or small intestine, and their association with amylases and pancreaticojejunostomy, pancreaticoduodenectomy, or duodenopancreatectomy.", "What is the effectiveness of drainage techniques, anastomotic leaks, and pancreatic fistulas after procedures involving the Ampulla of Vater, Pancreas, Bile Ducts, Duodenum, or related terms such as amylases and pancreatectomy or related procedures?", "What is the effectiveness of pancreatic drainage procedures and anastomotic leak prevention techniques, specifically in relation to amylase levels, for patients undergoing pancreatoduodenectomy or other forms of pancreatectomy?", "What is the effectiveness of pancreatic drainage techniques following pancreatoduodenectomy in relation to the occurrence of anastomotic leaks and pancreatic fistulas, and how do amylase levels impact these outcomes? Additionally, what is the impact of different types of pancreatectomy procedures, such as pancreaticojejunostomy or pancreaticoduodenectomy, on these outcomes? The search should include articles on the Ampulla of Vater, pancreas, bile ducts, and duodenum, as well as related keywords such as drain, leak, fistula, and amylase.", "What is the effectiveness of drainage and anastomotic leak prevention strategies in patients undergoing pancreatectomy or pancreaticoduodenectomy for conditions related to Ampulla of Vater, pancreas, bile ducts, or duodenum, and how does amylase testing relate to these strategies?", "What is the effectiveness of drainage and anastomotic leak management following pancreatectomy or pancreaticoduodenectomy, as measured by amylase levels, in patients with tumors of the Ampulla of Vater, Pancreas, Bile Ducts, or Duodenum?", "What is the effectiveness of drainage techniques in preventing anastomotic leaks and pancreatic fistulas in patients undergoing pancreatectomy, pancreaticoduodenectomy, or pancreaticojejunostomy? Specifically, I am interested in studies that focus on the amylase levels in bile or pancreatic fluid as an indicator of postoperative complications in the ampulla of Vater, pancreas, bile ducts, or duodenum.", "What is the effectiveness of different surgical techniques (such as Pancreaticoduodenectomy, Pancreaticojejunostomy, and Pancreatectomy) for treating drainage-related issues (including Anastomotic Leak and Pancreatic Fistula) in patients with conditions involving the Ampulla of Vater, Pancreas, Bile Ducts, and Duodenum, and how do amylase levels affect outcomes?", "What is the effectiveness of drainage techniques, anastomotic leaks, and pancreatic fistulas in relation to amylase levels following pancreatectomy or pancreaticoduodenectomy in patients with tumors of the Ampulla of Vater, Pancreas, Bile Ducts, Duodenum, or small bowel?"]}
{"id": "CD008759", "boolean": "(Platelet Count[mesh] OR PLT[All Fields] OR PDW[All Fields] OR MPV[All Fields] OR ((platelet*[All Fields] OR thrombocyt*[All Fields]) AND (count[All Fields] OR distribution[All Fields] OR volume[All Fields]))) AND (Splenomegaly[mesh] OR splenomegal*[All Fields] OR ((splenic*[All Fields] OR spleen*[All Fields]) AND (enlarg*[All Fields] OR hypertroph[All Fields] OR length[All Fields] OR palpable[All Fields] OR size[All Fields] OR diamet*[All Fields] OR index[All Fields] OR examin*[All Fields])))", "generated_query": ["What is the relationship between platelet count and splenomegaly, including the effects of thrombocytopenia and thrombocytosis, as well as any correlations between splenomegaly size and platelet levels, as determined by studies that use Platelet Count, PLT, PDW, MPV, or related keywords in conjunction with Splenomegaly, splenomegal*, splenic*, spleen*, or related terms indicating spleen enlargement, hypertrophy, palpable size, or exam findings?", "What is the correlation between platelet count and splenomegaly, and what are the diagnostic methods for detecting splenomegaly, including its size, length, and palpability, in patients with platelet disorders?", "What is the association between platelet count, platelet distribution width, mean platelet volume, or any terms related to platelets, and splenomegaly, or any terms related to spleen enlargement, including size, palpable, or diameter, in humans?", "What is the association between platelet count, PDW, MPV, and splenomegaly or splenic enlargement, hypertrophy, palpation, and size in the context of relevant medical literature?", "What is the relationship between platelet count and splenomegaly, and what are the potential clinical implications of this relationship? Retrieve articles discussing the association between platelet count, PLT, PDW, MPV, thrombocytopenia, and splenomegaly, as well as the various measures of spleen size including enlargement, hypertrophy, palpable, diameter, and index.", "What is the association between platelet count and splenomegaly? Can thrombocytopenia be a potential indicator of splenomegaly? Does the size or volume of the spleen have an impact on platelet count?", "What is the relationship between platelet count and splenomegaly?", "What is the association between platelet count and splenomegaly? Include studies that examine platelet count using Mesh or keywords such as PLT, PDW, MPV, thrombocyt*, and count, distribution, or volume, and studies that examine splenomegaly using Mesh or keywords such as splenomegal*, splenic*, spleen*, enlarg*, hypertroph*, length, palpable, size, diamet*, index, or examin*.", "What is the correlation between platelet count, PDW, MPV, and splenomegaly or splenomegalic symptoms, including spleen enlargement, palpable spleen, or spleen size, diameter, or index?", "What is the relationship between platelet count and splenomegaly, as measured by platelet count, PDW, MPV, thrombocyt*, count, distribution, and volume in combination with splenomegal*, splenic*, spleen*, enlarg*, hypertroph*, length, palpable, size, diamet*, index, and examin*?"]}
{"id": "CD010502", "boolean": "(Tonsillitis[mesh:noexp] OR Streptococcal Infections[mesh:noexp] OR Streptococcus pyogenes[mesh:noexp] OR Pharyngitis[mesh:noexp] OR Pharynx[mesh:noexp] OR tonsillitis[Text Word] OR sore throat*[Text Word] OR pharyngitis[Text Word] OR lancefield group a[Text Word] OR gabhs[Text Word] OR (\"group a\"[Text Word] AND streptococc*[Text Word]) OR (tonsillopharyngitis[Text Word] OR pharyngotonsillitis[Text Word]) OR (strep*[Text Word] AND (throat*[Text Word] OR pharyn*[Text Word] OR tonsil*[Text Word])) OR (beta-hemoly*[Text Word] OR beta-haemoly*[Text Word]) OR ((throat*[Text Word] OR pharyn*[Text Word] OR tonsil*[Text Word]) AND (infect*[Text Word] OR inflam*[Text Word])) OR (streptococcus pyogenes[Text Word] OR \"s. pyogenes\"[Text Word] OR \"s.pyogenes\"[Text Word])) AND (Immunochromatography[mesh:noexp] OR Antigens, Bacterial[mesh:noexp] OR Enzyme-Linked Immunosorbent Assay[mesh] OR Reagent Kits, Diagnostic[mesh:noexp] OR Immunoassay[mesh:noexp] OR Immunoenzyme Techniques[mesh] OR Immunosorbent Techniques[mesh:noexp] OR Point-of-Care Systems[mesh:noexp] OR icon strep a[Text Word] OR link 2 strep a rapid test[Text Word] OR quickvue strep a[Text Word] OR immunochromatograph*[Text Word] OR test pack strep a[Text Word] OR osom strep a[Text Word] OR acceava strep a[Text Word] OR poly stat strep a[Text Word] OR (radt[Text Word] OR radts[Text Word] OR rdt[Text Word] OR rdts[Text Word]) OR (antigen*[Text Word] AND detect*[Text Word]) OR (enzyme[Text Word] AND (immunoassay*[Text Word] OR immuno-assay*[Text Word] OR immunosorbent[Text Word])) OR ((rapid[Text Word] OR \"point of care\"[Text Word] OR \"near patient\"[Text Word] OR poc[Text Word] OR poct[Text Word] OR bedside[Text Word]) AND (test[Text Word] OR tests[Text Word] OR testing[Text Word] OR detect*[Text Word] OR diagnos*[Text Word] OR screen*[Text Word] OR kit[Text Word] OR kits[Text Word] OR assay*[Text Word])) OR (elisa[Text Word] OR elisas[Text Word] OR eia[Text Word] OR eias[Text Word]) OR (sandwich*[Text Word] AND assay*[Text Word]) OR (lateral flow[Text Word] AND assay[Text Word]) OR (optical[Text Word] AND (immunoassay*[Text Word] OR immuno-assay*[Text Word])) OR (oia[Text Word] OR oias[Text Word]))", "generated_query": ["What diagnostic tests are available for detecting Streptococcal Infections, Pharyngitis, Tonsillitis, or Streptococcus pyogenes, and how effective are they? Please include information on Immunochromatography, Antigens, Bacterial, Enzyme-Linked Immunosorbent Assay, Reagent Kits, Diagnostic, Immunoassay, Immunoenzyme Techniques, Immunosorbent Techniques, and Point-of-Care Systems.", "What is the diagnostic accuracy of immunochromatography, antigens bacterial, enzyme-linked immunosorbent assay, and other diagnostic reagent kits in detecting tonsillitis, streptococcal infections, Streptococcus pyogenes, pharyngitis, and pharynx infections caused by Lancefield group A or GABHS, using lateral flow assays, optical immunoassays, and other immunoenzyme techniques, as compared to traditional diagnostic methods?", "What diagnostic tests are effective for detecting tonsillitis, streptococcal infections, streptococcus pyogenes, pharyngitis, or pharynx infections caused by Lancefield Group A or GABHS, using immunochromatography, enzyme-linked immunosorbent assay, reagent kits, or other immunoassay techniques, including Point-of-Care Systems and rapid tests such as ICON Strep A, Link 2 Strep A Rapid Test, QuickVue Strep A, Test Pack Strep A, OSOM Strep A, Acceava Strep A, and Poly Stat Strep A?", "What is the diagnostic accuracy of immunochromatography, enzyme-linked immunosorbent assay, reagent kits, diagnostic, and other diagnostic tests in detecting tonsillitis, streptococcal infections, streptococcus pyogenes, pharyngitis, and other related conditions?", "What is the efficacy of immunochromatography, antigens, bacterial, enzyme-linked immunosorbent assay, reagent kits, diagnostic, immunoassay, immunoenzyme techniques, immunosorbent techniques, and point-of-care systems in diagnosing tonsillitis, streptococcal infections, streptococcus pyogenes, pharyngitis, pharynx, sore throat, lancefield group a, gabhs, beta-hemolytic streptococci, and streptococcus pyogenes infections?", "What is the diagnostic accuracy of immunochromatography, antigens, bacterial, enzyme-linked immunosorbent assay, reagent kits, diagnostic, immunoassay, immunoenzyme techniques, immunosorbent techniques, and point-of-care systems, including icon strep a, link 2 strep a rapid test, quickvue strep a, immunochromatograph, test pack strep a, osom strep a, acceava strep a, and poly stat strep a, as well as rapid tests (radt, radts, rdt, rdts), antigen detection, enzyme immunoassay, sandwich assay, lateral flow assay, optical immunoassay, and oia, for diagnosing tonsillitis, streptococcal infections, streptococcus pyogenes, pharyngitis, pharynx, sore throat, lancefield group a, gabhs, tonsillopharyngitis, pharyngotonsillitis, strep throat, and beta-hemolytic bacteria?", "What is the efficacy of immunochromatography, antigens, Enzyme-Linked Immunosorbent Assay, Reagent Kits, Diagnostic, Immunoassay, Immunoenzyme Techniques, and Immunosorbent Techniques in detecting Tonsillitis, Streptococcal Infections, Streptococcus pyogenes, Pharyngitis, Pharynx, tonsillitis, sore throat*, pharyngitis, lancefield group a, gabhs, \"group a\" and streptococc*, tonsillopharyngitis, pharyngotonsillitis, strep* and (throat* or pharyn* or tonsil*), beta-hemoly* or beta-haemoly*, streptococcus pyogenes, \"s. pyogenes\", or \"s.pyogenes\"?", "What diagnostic tests are available for detecting Streptococcus pyogenes and related infections such as Tonsillitis, Streptococcal Infections, and Pharyngitis, and what is their accuracy in comparison to each other and to culture-based methods?", "What is the effectiveness of immunochromatography, antigens, bacterial, enzyme-linked immunosorbent assay, reagent kits, diagnostic, immunoassay, immunoenzyme techniques, immunosorbent techniques, and point-of-care systems in the diagnosis of tonsillitis, streptococcal infections, Streptococcus pyogenes, pharyngitis, Pharynx, tonsillitis, sore throat, pharyngitis, lancefield group a, gabhs, \"group a\" and streptococc*, tonsillopharyngitis, pharyngotonsillitis, strep* and throat*, pharyn* or tonsil*, beta-hemoly*, beta-haemoly*, Streptococcus pyogenes, \"s. pyogenes\" or \"s.pyogenes\" infections?", "What diagnostic tests are effective in detecting Streptococcus pyogenes, tonsillitis, pharyngitis, sore throat, or streptococcal infections? Specifically, I am looking for studies that evaluate the use of immunochromatography, enzyme-linked immunosorbent assay, reagent kits, diagnostic tests, immunoassay, immunoenzyme techniques, immunosorbent techniques, point-of-care systems, rapid tests, antigen detection tests, or optical immunoassays for the detection of these conditions."]}
{"id": "CD011420", "boolean": "(test[tiab] OR assay[tiab] OR antigen[tiab] OR Ag[tiab] OR lateral flow assay*[tiab] OR urine antigen[tiab] OR point of care[tiab]) AND (LAM[tiab] OR \"lipoarabinomannan\"[Supplementary Concept] OR lipoarabinomannan[tiab]) AND (Tuberculosis[Mesh] OR Mycobacterium tuberculosis[Mesh] OR tuberculosis[tiab] Or TB[tiab]) AND 1940/01/01:2015/02/28[crdt] ", "generated_query": ["What is the effectiveness of diagnostic tests such as test, assay, antigen, Ag, lateral flow assay, urine antigen, and point of care in detecting tuberculosis caused by Mycobacterium tuberculosis using LAM or lipoarabinomannan as a biomarker from January 1940 to February 2015?", "What is the diagnostic accuracy of LAM or its variants for the detection of tuberculosis using urine, serum, or plasma samples in adults, compared to standard diagnostic tests, between January 1940 and February 2015?", "What is the effectiveness of diagnostic tests for tuberculosis, specifically those utilizing the detection of LAM (lipoarabinomannan) in urine or through lateral flow assays at point of care settings, as compared to traditional methods of diagnosis? Please provide relevant studies published between January 1940 and February 2015.", "\"What is the efficacy of point of care tests, lateral flow assays, and urine antigen tests in detecting tuberculosis using the biomarker LAM or lipoarabinomannan in patients infected with Mycobacterium tuberculosis within the time frame of January 1940 to February 2015?\"", "What is the efficacy of diagnostic tests (such as urine antigen testing, point-of-care testing, and lateral flow assays) for detecting tuberculosis caused by Mycobacterium tuberculosis using LAM or lipoarabinomannan as the biomarker, within the time frame of January 1940 to February 2015?", "What is the effectiveness of tests, assays, antigen detection methods, lateral flow assays, urine antigen tests, and point-of-care tools for diagnosing tuberculosis caused by Mycobacterium tuberculosis using LAM or lipoarabinomannan as biomarkers, between January 1940 and February 2015?", "What is the efficacy of point-of-care tests, including lateral flow assays and urine antigen tests, for diagnosing tuberculosis caused by Mycobacterium tuberculosis using the biomarker LAM or lipoarabinomannan, as determined by studies published between 1940 and February 2015?", "What is the efficacy of test, assay, antigen, lateral flow assay, urine antigen, and point of care methods in the diagnosis of tuberculosis caused by Mycobacterium tuberculosis using LAM or lipoarabinomannan as a marker, between January 1940 and February 2015?", "What is the diagnostic accuracy of various tests, including lateral flow assays and urine antigen assays, for detecting tuberculosis caused by Mycobacterium tuberculosis, specifically targeting the biomarker LAM (lipoarabinomannan), between the years 1940 and 2015?", "What is the diagnostic accuracy of LAM, lateral flow assay, urine antigen and point of care tests in detecting tuberculosis caused by Mycobacterium tuberculosis between 1940 and February 2015?"]}
{"id": "CD012599", "boolean": "(chorionic villi sampling[mesh:noexp] OR INHIBINS[mesh] OR alpha-Fetoproteins[mesh] OR Chorionic Gonadotropin, beta Subunit, Human[mesh] OR Area under curve[mesh:noexp] OR amniocentesis[mesh:noexp] OR false positive reactions[mesh] OR Prenatal Diagnosis[mesh] OR false negative reactions[mesh] OR Pregnancy-Associated Plasma Protein-A[mesh] OR ROC curve[mesh:noexp] OR papp-a[All Fields] OR human chorionic gonadotropin[All Fields] OR inhibin a[All Fields] OR diagnos*[Title/Abstract] OR accura*[All Fields] OR AUC[All Fields] OR ultrasound[All Fields] OR marker*[All Fields] OR tricuspid regurgitation[All Fields] OR specific*[All Fields] OR \"reproducibility of results\"[All Fields] OR predict*[All Fields] OR sensitiv*[All Fields] OR reference standard*[All Fields] OR afp[All Fields] OR screen*[All Fields] OR detect*[All Fields] OR reference value*[All Fields] OR pregnancy associated plasma protein a[All Fields] OR ue3[All Fields] OR chorion* vill* sampling[All Fields] OR ROC[All Fields] OR nuchal translucency[All Fields] OR ductus venosus[All Fields] OR likelihood ratio*[All Fields] OR alphafetoprotein*[All Fields] OR alpha-fetoprotein*[All Fields] OR nasal bone[All Fields] OR (b-hcg[All Fields] OR bhcg[All Fields]) OR (unconjugated estriol[All Fields] OR unconjugated oestriol[All Fields]) OR (false positive*[All Fields] OR false negative*[All Fields])) AND (Aneuploidy[mesh:noexp] OR Mosaicism[mesh:noexp] OR Down Syndrome[mesh] OR down syndrome[All Fields] OR trisomy 21[All Fields] OR aneuploidy[All Fields] OR mosaicism[All Fields] OR downs syndrome[All Fields])", "generated_query": ["What is the diagnostic accuracy of chorionic villi sampling, amniocentesis, ultrasound, and other markers in detecting aneuploidy, mosaicism, or Down syndrome? How reliable are false positive and false negative results in prenatal diagnosis? What are the reference values and sensitivity of alpha-fetoprotein, human chorionic gonadotropin, pregnancy-associated plasma protein A, inhibin A, and other markers in predicting aneuploidy or Down syndrome? What is the reproducibility of the results?", "What is the accuracy of prenatal diagnostic tests, such as chorionic villi sampling, amniocentesis, and ultrasound markers, in detecting aneuploidy or mosaicism, including Down Syndrome or trisomy 21? How reliable are these tests in terms of sensitivity, specificity, and likelihood ratios? Can inhibins, alpha-Fetoproteins, or other biomarkers improve the diagnostic accuracy? What are the false positive and false negative rates? Is there any difference in reproducibility of results across different reference values, reference standards, or screening methods?", "What is the diagnostic accuracy and reproducibility of chorionic villi sampling, amniocentesis, ultrasound markers (including nasal bone, tricuspid regurgitation, nuchal translucency, and ductus venosus), and maternal serum markers (including PAPP-A, hCG, inhibin A, AFP, and unconjugated estriol) in the prenatal diagnosis of aneuploidy (specifically Down syndrome and mosaicism), as measured by the ROC curve, area under the curve (AUC), sensitivity, specificity, likelihood ratios, and reference values?", "What is the diagnostic accuracy of chorionic villi sampling, inhibins, alpha-Fetoproteins, Chorionic Gonadotropin, beta Subunit, Human, Area under curve, amniocentesis, false positive reactions, Prenatal Diagnosis, false negative reactions, Pregnancy-Associated Plasma Protein-A, ROC curve, papp-a, human chorionic gonadotropin, inhibin a, diagnos*, accura*, AUC, ultrasound, marker*, tricuspid regurgitation, specific*, \"reproducibility of results\", predict*, sensitiv*, reference standard*, afp, screen*, detect*, reference value*, pregnancy associated plasma protein a, ue3, chorion* vill* sampling, ROC, nuchal translucency, ductus venosus, likelihood ratio*, alphafetoprotein*, alpha-fetoprotein*, nasal bone, b-hcg, bhcg, unconjugated estriol, unconjugated oestriol, false positive*, false negative* for the diagnosis of Aneuploidy, Mosaicism, Down Syndrome, trisomy 21, aneuploidy, mosaicism, and downs syndrome?", "What is the accuracy and reliability of prenatal diagnostic markers, such as chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers including inhibins, alpha-fetoproteins, chorionic gonadotropin, pregnancy-associated plasma protein-A, and unconjugated estriol, in detecting aneuploidy and mosaicism, including Down Syndrome or trisomy 21, as evidenced by studies evaluating sensitivity, specificity, likelihood ratios, area under the ROC curve, and false positive and false negative rates, and how can their results be reproduced consistently?", "What is the accuracy of prenatal diagnostic tests for detecting aneuploidy, mosaicism, or Down syndrome, including chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers such as inhibins, alpha-fetoproteins, and chorionic gonadotropin, as well as reference values, likelihood ratios, and ROC curves, and how do false positive and false negative reactions affect their performance?", "What is the accuracy and sensitivity of various diagnostic markers, including chorionic villi sampling, amniocentesis, inhibins, alpha-fetoproteins, and chorionic gonadotropin, in detecting aneuploidy, mosaicism, and Down syndrome in prenatal diagnosis? Additionally, what is the reliability of these markers in terms of false positive and false negative results, as well as the reproducibility of results? Other relevant markers to consider include Prenatal Diagnosis, Pregnancy-Associated Plasma Protein-A, and Tricuspid Regurgitation, as well as the use of ROC curves, likelihood ratios, and reference values.", "What is the accuracy and reliability of different prenatal diagnostic tests, including chorionic villi sampling, amniocentesis, ultrasound, and various biomarkers such as inhibins, alpha-fetoproteins, and human chorionic gonadotropin, for detecting aneuploidies such as Down syndrome, trisomy 21, and mosaicism? Specifically, how do false positive and false negative rates, as well as the area under the curve and ROC curves, vary among these tests? Are there specific markers, reference values, or likelihood ratios that are particularly useful in predicting aneuploidies, and how do these compare to traditional screening methods such as nuchal translucency and ductus venosus measurements? Additionally, what is the reproducibility of results across different studies, and are there specific limitations or biases that need to be taken into account when interpreting the findings?", "What is the accuracy of prenatal diagnostic tests in detecting aneuploidy, mosaicism, and Down Syndrome? Specifically, I am interested in the effectiveness of chorionic villi sampling, amniocentesis, alpha-fetoprotein, chorionic gonadotropin, Prenatal Diagnosis, Pregnancy-Associated Plasma Protein-A, nuchal translucency, and ductus venosus, as well as the reproducibility of results, ROC curves, and likelihood ratios. Additionally, I am interested in markers such as inhibins, false positive and negative reactions, reference values, and nasal bone, and the use of ultrasound and b-hcg in detecting aneuploidy and Down Syndrome.", "What is the diagnostic accuracy of chorionic villi sampling, inhibins, alpha-fetoproteins, chorionic gonadotropin, amniocentesis, false positive reactions, false negative reactions, Pregnancy-Associated Plasma Protein-A, and other markers in the prenatal diagnosis of Down Syndrome, trisomy 21, and other aneuploidies, as measured by area under the ROC curve, sensitivity, specificity, likelihood ratios, and reference values, and what is the reproducibility of results?"]}
{"id": "CD011686", "boolean": "(Guideline[mesh] OR Guideline Adherence[mesh:noexp] OR guidelines as topic[mesh] OR algorithms[mesh] OR Clinical Protocols[mesh] OR Decision Trees[mesh:noexp] OR decision support techniques[mesh] OR Critical Pathways[mesh:noexp] OR triage[mesh:noexp] OR National Emergency X-Radiography[All Fields] OR ((Clinical[All Fields] OR critical[All Fields] OR treatment[All Fields]) AND (pathway*[All Fields] OR protocol*[All Fields])) OR (triage[All Fields] OR protocol*[All Fields]) OR (Canadian c-spine[All Fields] OR Canadian cervical spine[All Fields]) OR (algorithm*[All Fields] OR guideline*[All Fields]) OR (decision[All Fields] AND (tree*[All Fields] OR rule*[All Fields] OR tool*[All Fields])) OR (NEXUS[All Fields] OR CCR[All Fields])) AND (Pediatrics[mesh] OR Child[mesh] OR Infant[mesh] OR Adolescent[mesh:noexp] OR (neonate*[All Fields] OR newborn*[All Fields] OR new-born*[All Fields]) OR (Pediatric*[All Fields] OR paediatric*[All Fields] OR peadiatric*[All Fields]) OR (Child*[All Fields]) OR (infant*[All Fields] OR baby[All Fields] OR babies[All Fields] OR toddler*[All Fields]) OR (adolescen*[All Fields] OR juvenile*[All Fields] OR youth*[All Fields] OR teen*[All Fields] OR preteen*[All Fields])) AND (Cervical Vertebrae[mesh] OR Neck Injuries[mesh] OR Spinal Injuries[mesh] OR Spinal Cord Injuries[mesh] OR spinal fractures[mesh:noexp] OR (clear*[All Fields] AND (Cervical spine[All Fields] OR c-spine[All Fields])) OR (cervical[All Fields] AND (trauma*[All Fields] OR injur*[All Fields] OR fracture*[All Fields] OR sublux*[All Fields] OR dislocat*[All Fields] OR avuls*[All Fields] OR instab*[All Fields])) OR (Spinal cord injury without radiographic abnormality[All Fields] OR SCIWORA[All Fields])) AND (physical examination[mesh] OR neurologic examination[mesh:noexp] OR trauma severity indices[mesh] OR \"Severity of Illness Index\"[mesh:noexp] OR X-Rays[mesh:noexp] OR Tomography[mesh:noexp] OR Tomography, Emission-Computed[mesh] OR Tomography, X-Ray[mesh] OR Magnetic Resonance Imaging[mesh] OR Radiography[mesh:noexp] OR Imaging[All Fields] OR MRI*[All Fields] OR (X ray*[All Fields] OR x-ray*[All Fields] OR xray*[All Fields] OR radiogra*[All Fields] OR roentgenogra*[All Fields]) OR (CT*[All Fields] OR Computed Tomography[All Fields] OR CAT scan*[All Fields]) OR ((neurolog*[All Fields] OR physical*[All Fields] OR clinical*[All Fields]) AND (exam*[All Fields] OR assess*[All Fields] OR sign*[All Fields])))", "generated_query": ["\"What are the most effective guidelines, algorithms, and decision support techniques for pediatric cervical spine injuries, and what physical and neurologic examinations, trauma severity indices, and imaging techniques are recommended for diagnosis and severity assessment?\"", "What is the efficacy of clinical guidelines, algorithms, and decision support techniques in the management of pediatric cervical spine injuries? How does the severity of illness index and physical and neurologic examinations aid in the diagnosis of these injuries? What imaging techniques, such as X-rays, CT scans, and MRI, are most effective in assessing and diagnosing cervical spine injuries in children and adolescents?", "What are the most effective guidelines, protocols, algorithms, and decision support techniques for managing pediatric cervical spine and spinal cord injuries? Can physical and neurologic examinations, trauma severity indices, X-rays, CT scans, and MRI imaging accurately diagnose and classify the severity of these injuries in children, infants, and adolescents?", "What are the most effective clinical protocols, guidelines, decision support techniques, and algorithms for pediatric patients with spinal injuries, including cervical vertebrae, neck injuries, and spinal cord injuries? What are the most accurate physical and neurologic examination methods, trauma severity indices, and imaging techniques, such as X-rays, computed tomography, and magnetic resonance imaging, for diagnosing and assessing the severity of pediatric spinal injuries?", "What are the best guidelines, protocols, decision support techniques, and algorithms for diagnosing and treating cervical spine injuries in pediatric patients? How can physical and neurologic examinations, trauma severity indices, X-rays, CT scans, MRI, and other imaging techniques be used to accurately assess the severity of the injury and determine the appropriate course of treatment?", "What are the most effective clinical guidelines, decision support techniques, and protocols for assessing and treating pediatric cervical spine injuries, including spinal fractures and cord injuries? Which physical and neurological examination methods, trauma severity indices, and imaging techniques, such as X-rays, CT scans, and MRI, are most useful in evaluating the severity of illness in children with cervical spine trauma?", "What are the most effective clinical protocols, decision support techniques, and guidelines for diagnosing and treating cervical spine injuries in children and adolescents, as determined by physical and neurologic examinations, trauma severity indices, and various imaging techniques such as X-rays, CT scans, and MRI?", "What are the best guidelines, algorithms, decision support techniques, and clinical protocols for managing neck and spinal injuries in pediatric patients, and what is the role of physical and neurologic examination, trauma severity indices, and imaging modalities such as X-rays, CT scans, and MRI in assessing the severity and identifying potential spinal cord injuries?", "What are the most effective guidelines, algorithms, and decision support techniques for diagnosing and managing cervical spine injuries in infants, children, and adolescents? Specifically, what physical and neurologic examination methods, trauma severity indices, and imaging technologies (such as X-rays, MRI, and CT scans) are most useful in identifying spinal fractures, subluxations, dislocations, avulsions, and instability?", "What are the most effective guidelines, algorithms, and decision support techniques for triaging and treating pediatric patients with spinal cord injuries, cervical vertebrae fractures, or neck injuries? What is the role of physical and neurologic examination, trauma severity indices, X-rays, CT scans, and MRI in assessing the severity of illness and guiding treatment decisions for these patients?"]}
